10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10–Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2013

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 000-50976

HURON CONSULTING GROUP INC.

(Exact name of registrant as specified in its charter)

Delaware	01-0666114
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification Number)

550 West Van Buren Street

Chicago, Illinois

60607

(Address of principal executive offices)

(Zip Code)

(312) 583-8700

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	x	Accelerated filer	¨
Non-accelerated filer	¨	Smaller reporting company	¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

As of April 18, 2013, 23,277,877 shares of the registrant’s common stock, par value $0.01 per share, were outstanding.

Huron Consulting Group Inc.

HURON CONSULTING GROUP INC.

INDEX

	Page
Part I – Financial Information
Item 1. Consolidated Financial Statements
Consolidated Balance Sheets		1
Consolidated Statements of Earnings and Other Comprehensive Income		2
Consolidated Statement of Stockholders’ Equity		3
Consolidated Statements of Cash Flows		4
Notes to Consolidated Financial Statements		5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		17
Item 3. Quantitative and Qualitative Disclosures About Market Risk		31
Item 4. Controls and Procedures		32
Part II – Other Information
Item 1. Legal Proceedings		32
Item 1A. Risk Factors		33
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		33
Item 3. Defaults Upon Senior Securities		33
Item 4. Mine Safety Disclosures		33
Item 5. Other Information		33
Item 6. Exhibits		34
Signature		35

PART I — FINANCIAL INFORMATION

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

HURON CONSULTING GROUP INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share amounts)

(Unaudited)

	March 31, 2013			December 31, 2012
Assets
Current assets:
Cash and cash equivalents	$	5,749		$	25,162
Receivables from clients, net		101,549			97,510
Unbilled services, net		59,123			47,232
Income tax receivable		1,003			192
Deferred income taxes, net		9,631			14,751
Prepaid expenses and other current assets		13,914			15,525
Total current assets		190,969			200,372
Property and equipment, net		33,269			33,805
Other non-current assets		15,584			15,322
Intangible assets, net		17,337			18,879
Goodwill		518,916			519,522
Total assets	$	776,075		$	787,900
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$	6,978		$	8,461
Accrued expenses		15,786			17,692
Accrued payroll and related benefits		32,869			61,672
Bank borrowings, current portion		25,000			—
Accrued consideration for business acquisitions, current portion		5,586			5,640
Income tax payable		165			7,872
Deferred revenues		15,345			15,388
Total current liabilities		101,729			116,725
Non-current liabilities:
Deferred compensation and other liabilities		7,140			6,973
Bank borrowings, net of current portion		177,500			192,500
Deferred lease incentives		6,874			6,936
Deferred income taxes		15,784			14,560
Accrued consideration for business acquisitions, net of current portion		4,956			4,885
Total non-current liabilities		212,254			225,854
Commitments and Contingencies
Stockholders’ equity
Common stock; $0.01 par value; 500,000,000 shares authorized; 25,184,665 and 24,793,327 shares issued at March 31, 2013 and December 31, 2012, respectively		243			240
Treasury stock, at cost, 1,893,745 and 1,880,809 shares at March 31, 2013 and December 31, 2012, respectively		(84,137	)		(83,715	)
Additional paid-in capital		427,607			420,825
Retained earnings		120,667			109,330
Accumulated other comprehensive loss		(2,288	)		(1,359	)
Total stockholders’ equity		462,092			445,321
Total liabilities and stockholders’ equity	$	776,075		$	787,900

The accompanying notes are an integral part of the consolidated financial statements.

1

HURON CONSULTING GROUP INC.

CONSOLIDATED STATEMENTS OF EARNINGS AND OTHER COMPREHENSIVE INCOME

(In thousands, except per share amounts)

(Unaudited)

	Three Months Ended March 31,
	2013			2012
Revenues and reimbursable expenses:
Revenues	$	164,036		$	138,637
Reimbursable expenses		15,336			13,796
Total revenues and reimbursable expenses		179,372			152,433
Direct costs and reimbursable expenses (exclusive of depreciation and amortization shown in operating expenses):
Direct costs		106,128			96,781
Amortization of intangible assets and software development costs		658			1,142
Reimbursable expenses		15,351			13,818
Total direct costs and reimbursable expenses		122,137			111,741
Operating expenses:
Selling, general and administrative		32,263			30,067
Restructuring charges		—			830
Restatement related expenses		—			1,505
Litigation settlement gain		(1,150	)		—
Depreciation and amortization		4,779			4,653
Total operating expenses		35,892			37,055
Operating income		21,343			3,637
Other income (expense), net:
Interest expense, net of interest income		(1,863	)		(1,866	)
Other income, net		13			333
Total other expense, net		(1,850	)		(1,533	)
Income from continuing operations before income tax expense		19,493			2,104
Income tax expense		8,124			1,517
Net income from continuing operations		11,369			587
(Loss) income from discontinued operations, net of tax		(32	)		269
Net income	$	11,337		$	856
Net earnings per basic share:
Net income from continuing operations	$	0.51		$	0.03
Income from discontinued operations, net of tax	$	—		$	0.01
Net income	$	0.51		$	0.04
Net earnings per diluted share:
Net income from continuing operations	$	0.51		$	0.03
Income from discontinued operations, net of tax	$	(0.01	)	$	0.01
Net income	$	0.50		$	0.04
Weighted average shares used in calculating earnings per share:
Basic		22,139			21,775
Diluted		22,487			22,164
Comprehensive income:
Net income	$	11,337		$	856
Foreign currency translation (loss) gain, net of tax		(997	)		239
Unrealized gain on cash flow hedging instruments, net of tax		68			49
Other comprehensive (loss) income		(929	)		288
Comprehensive income	$	10,408		$	1,144

The accompanying notes are an integral part of the consolidated financial statements.

2

HURON CONSULTING GROUP INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(In thousands, except share amounts)

(Unaudited)

											Additional					Accumulated Other
	Common Stock				Treasury Stock						Paid-In			Retained		Comprehensive			Stockholders’
	Shares		Amount		Shares			Amount			Capital			Earnings		Income (Loss)			Equity
Balance at December 31, 2012		23,904,125	$	240		(1,889,465	)	$	(83,715	)	$	420,825		$	109,330	$	(1,359	)	$	445,321
Comprehensive income															11,337		(929	)		10,408
Issuance of common stock in connection with:
Restricted stock awards, net of cancellations		310,001		3		3,549			143			(146	)							—
Exercise of stock options		20,211		—								27								27
Share-based compensation												6,323								6,323
Shares redeemed for employee tax withholdings						(16,283	)		(565	)										(565	)
Income tax benefit on share-based compensation												578								578
Balance at March 31, 2013		24,234,337	$	243		(1,902,199	)	$	(84,137	)	$	427,607		$	120,667	$	(2,288	)	$	462,092

The accompanying notes are an integral part of the consolidated financial statements.

3

HURON CONSULTING GROUP INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Three Months Ended March 31,
	2013			2012
Cash flows from operating activities:
Net income	$	11,337		$	856
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		5,437			6,621
Share-based compensation		4,635			4,842
Allowances for doubtful accounts and unbilled services		6,953			2,246
Deferred income taxes		6,083			3,344
Changes in operating assets and liabilities, net of businesses acquired:
(Increase) decrease in receivables from clients		(4,742	)		2,133
(Increase) decrease in unbilled services		(18,423	)		4,456
(Increase) decrease in current income tax receivable / payable, net		(8,513	)		2,379
(Increase) decrease in other assets		2,459			1,853
Increase (decrease) in accounts payable and accrued liabilities		(3,000	)		3,492
Increase (decrease) in accrued payroll and related benefits		(27,018	)		(36,795	)
Increase (decrease) in deferred revenues		(34	)		(7,978	)
Net cash used in operating activities		(24,826	)		(12,551	)
Cash flows from investing activities:
Purchases of property and equipment, net		(3,576	)		(5,267	)
Net investment in life insurance policies		(507	)		(361	)
Purchases of businesses, net of cash acquired		—			(31,298	)
Capitalization of internally developed software		(692	)		—
Net cash used in investing activities		(4,775	)		(36,926	)
Cash flows from financing activities:
Proceeds from exercise of stock options		27			29
Shares redeemed for employee tax withholdings		(565	)		(3,710	)
Tax benefit from share-based compensation		803			1,116
Proceeds from borrowings under credit facility		22,000			93,000
Repayments on credit facility		(12,000	)		(42,500	)
Payments of capital lease obligations		—			(5	)
Net cash provided by financing activities		10,265			47,930
Effect of exchange rate changes on cash		(77	)		430
Net decrease in cash and cash equivalents		(19,413	)		(1,117	)
Cash and cash equivalents at beginning of the period		25,162			5,080
Cash and cash equivalents at end of the period	$	5,749		$	3,963

The accompanying notes are an integral part of the consolidated financial statements.

4

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

1.       Description of Business

We are a leading provider of operational and financial consulting services. We help clients in diverse industries improve performance, reduce costs, leverage technology, process and review large amounts of complex data, address regulatory changes, recover from distress and stimulate growth. Our professionals employ their expertise in administration, management, finance and operations to provide our clients with specialized analyses and customized advice and solutions that are tailored to address each client’s particular challenges and opportunities to deliver sustainable and measurable results. We provide consulting services to a wide variety of both financially sound and distressed organizations, including healthcare organizations, leading academic institutions, Fortune 500 companies, governmental entities and law firms.

2.       Basis of Presentation

The accompanying unaudited Consolidated Financial Statements reflect the financial position, results of operations and cash flows as of and for the three months ended March 31, 2013 and 2012. These financial statements have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10-Q. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements. In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair presentation of our financial position, results of operations and cash flows for the interim periods presented in conformity with GAAP. These financial statements should be read in conjunction with the Consolidated Financial Statements and notes thereto for the year ended December 31, 2012 included in our Annual Report on Form 10-K.

Certain amounts reported in the previous year have been reclassified to conform to the 2013 presentation. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.

3.       New Accounting Pronouncements

In February 2013, the FASB issued ASU No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, which amends current accounting guidance on comprehensive income. The guidance requires an entity to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income if the amount is reclassified to net income in its entirety in the same reporting period. For other amounts not required to be reclassified in their entirety to net income in the same reporting period, a cross reference to other disclosures that provide additional detail about the reclassification amounts is required. The Company adopted this guidance effective January 1, 2013. The guidance required a change in disclosure only and did not have any effect on the Company’s consolidated financial statements.

In March 2013, the FASB issued ASU No. 2013-05, Parent’s Accounting for the Cumulative Translation Adjustment Upon Derecognition of Certain Subsidiaries or Groups of Assets Within a Foreign Entity or of an Investment in a Foreign Entity, which amends current accounting guidance on foreign currency matters. This guidance requires that the entire amount of a cumulative translation adjustment related to an entity’s investment in a foreign entity should be released when there has been a: (i) sale of a subsidiary or group of net assets within a foreign entity and the sale represents the substantially complete liquidation of the investment in the foreign entity, (ii) loss of a controlling financial interest in an investment in a foreign entity, and (iii) step acquisition for a foreign entity. This guidance will be effective for the Company beginning in the first quarter of 2014. We do not expect the adoption to have a material impact on our consolidated financial statements.

4.       Discontinued Operations

In recent years, we have undertaken several separate initiatives to divest certain practices within the Huron Financial segment in order to enable us to devote more of our energy and financial resources to the remaining businesses of the Company where we have a more substantial market presence. Most recently, on December 30, 2011, we sold the Accounting Advisory (“AA”) practice to a group of investors including the managing director of the practice at the time and recognized a loss of $1.9 million in connection with the sale.

5

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

The operating results of AA are reported as “discontinued operations.” All other operations of the business are considered “continuing operations.” Summarized operating results of discontinued operations are presented in the following table:

	Three Months Ended March  31,
	2013			2012
Revenues	$	33		$	390
(Loss) income from discontinued operations before income tax expense	$	(53	)	$	424
Net (loss) income from discontinued operations	$	(32	)	$	269

There were no significant assets or liabilities related to discontinued operations in the Consolidated Balance Sheets as of March 31, 2013 or December 31, 2012.

5.       Goodwill and Intangible Assets

The table below sets forth the changes in the carrying amount of goodwill by segment for the three months ended March 31, 2013.

	Current Segments
Former Segments	Huron Healthcare		Huron Legal			Huron Education and Life Sciences		Huron Financial			Total
Health and Education Consulting	$	355,880	$	—		$	94,601	$	—		$	450,481
Legal Consulting		—		52,947			—		—			52,947
Financial Consulting		—		—			—		159,077			159,077
Total new alignment as of December 31, 2012		355,880		52,947			94,601		159,077			662,505
Accumulated impairment		—		—			—		(142,983	)		(142,983	)
Goodwill, net as of December 31, 2012		355,880		52,947			94,601		16,094			519,522
Foreign currency translation		—		(606	)		—		—			(606	)
Goodwill, net as of March 31, 2013	$	355,880	$	52,341		$	94,601	$	16,094		$	518,916

During the first quarter of 2013, we changed our internal financial reporting structure. Under the new structure, our former Health and Education Consulting segment became two separate segments: Huron Healthcare and Huron Education and Life Sciences. In addition, certain immaterial practices which were historically part of our Health and Education Consulting segment were combined and disclosed in our All Other segment. The Legal Consulting segment is now referred to as Huron Legal and the Financial Consulting segment is now referred to as Huron Financial. The structure of the Legal Consulting and Financial Consulting segments did not change. As a result of these changes, we now have five reporting segments, which are the same as our operating segments and reporting units.

In accordance with ASC 350, “Intangibles – Goodwill and Other”, we reassigned the goodwill balance of the Health and Education Consulting segment using the relative fair value approach based on an evaluation of expected future discounted cash flows. Based on this relative fair value analysis, we reassigned $355.9 million of goodwill to Huron Healthcare and $94.6 million of goodwill to Huron Education and Life Sciences.

In conjunction with the goodwill reassignment, we performed the first step of the goodwill impairment test for the goodwill balances within our Huron Healthcare and Huron Education and Life Sciences reporting units as of January 2, 2013. Based on the result of the first step of the goodwill impairment test, we determined that the fair values of our Huron Healthcare and Huron Education and Life Sciences reporting units exceeded their carrying values. Since the fair values of both reporting units exceeded their carrying values, the second step of the goodwill impairment test was not necessary.

In estimating the fair value of our Huron Healthcare and Huron Education and Life Sciences reporting units, we relied on a combination of the income approach and the market approach, utilizing the guideline company method, with a fifty-fifty weighting. For companies providing services similar to those provided by us, the income and market approaches will generally provide the most reliable indications of value because the value of such companies is dependent on their ability to generate earnings.

6

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

In the income approach, we utilized a discounted cash flow analysis, which involved estimating the expected after-tax cash flows that will be generated by our reporting units and then discounting those cash flows to present value reflecting the relevant risks associated with the reporting units and the time value of money. This approach requires the use of significant estimates and assumptions, including long-term projections of future cash flows, market conditions, discount rates reflecting the risk inherent in future cash flows, revenue growth, perpetual growth rates and profitability, among others. In estimating future cash flows, we relied on an internally generated six-year forecast. For periods after the six-year forecast, we assumed a 3.5% long-term annual revenue growth rate. Our forecast is based on our historical experience, current backlog, expected market demand, and other industry information. Our discounted cash flow analysis assumed a 13% weighted average cost of capital (“WACC”) discount rate for each reporting unit.

In the market approach, we utilized the guideline company method, which involved calculating valuation multiples based on operating data from guideline publicly traded companies. Multiples derived from guideline companies provide an indication of how much a knowledgeable investor in the marketplace would be willing to pay for a company. These multiples were then adjusted for factors similar to those used in a discounted cash flow analysis and applied to the operating data for our reporting units to arrive at an indication of value.

Determining the fair value of a reporting unit requires us to make significant judgments, estimates and assumptions. While we believe that the estimates and assumptions underlying our valuation methodology are reasonable, these estimates and assumptions could have a significant impact on whether or not an impairment charge is recognized and also the magnitude of any such charge. The results of an impairment analysis are as of a point in time. There is no assurance that the actual future earnings or cash flows of our reporting units will not differ significantly from our projections. We will monitor any changes to our assumptions and will evaluate goodwill as deemed warranted during future periods. Any significant decline in our operations could result in goodwill impairment charges.

Intangible assets as of March 31, 2013 and December 31, 2012 consisted of the following:

		March 31, 2013				December 31, 2012
	Useful Life in Years	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Customer relationships	3 to 13	$	24,634	$	11,219	$	24,738	$	10,268
Non-competition agreements	1 to 6		4,684		3,295		4,684		3,067
Trade names	1 to 8		150		20		150		8
Technology and software	5		4,041		1,953		4,041		1,751
Document reviewer database	3		450		135		450		90
Total		$	33,959	$	16,622	$	34,063	$	15,184

Identifiable intangible assets with finite lives are amortized over their estimated useful lives. The majority of customer relationships are amortized on an accelerated basis to correspond to the cash flows expected to be derived from the relationships. All other customer relationships, non-competition agreements, trade names, technology and software, and the document reviewer database are amortized on a straight-line basis.

Intangible assets amortization expense was $1.5 million and $1.6 million for the three months ended March 31, 2013 and 2012, respectively. Estimated annual intangible assets amortization expense is $5.8 million for 2013, $4.5 million for 2014, $3.1 million for 2015, $1.8 million for 2016, $1.2 million for 2017 and $0.7 million for 2018. Actual future amortization expense could differ from these estimated amounts as a result of future acquisitions and other factors.

7

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

6.       Earnings Per Share

Basic earnings per share excludes dilution and is computed by dividing net income by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Diluted earnings per share reflects the potential reduction in earnings per share that could occur if securities or other contracts to issue common stock were exercised or converted into common stock under the treasury stock method. Earnings per share under the basic and diluted computations are as follows:

	Three Months Ended March 31,
	2013			2012
Net income from continuing operations	$	11,369		$	587
(Loss) income from discontinued operations, net of tax		(32	)		269
Net income	$	11,337		$	856
Weighted average common shares outstanding – basic		22,139			21,775
Weighted average common stock equivalents		348			389
Weighted average common shares outstanding – diluted		22,487			22,164
Net earnings per basic share:
Net income from continuing operations	$	0.51		$	0.03
Income from discontinued operations, net of tax		—			0.01
Net income	$	0.51		$	0.04
Net earnings per diluted share:
Net income from continuing operations	$	0.51		$	0.03
(Loss) income from discontinued operations, net of tax		(0.01	)		0.01
Net income	$	0.50		$	0.04

The computation of diluted earnings per share excludes unvested restricted common stock, outstanding options and other common stock equivalents in periods where inclusion of such potential common stock instruments would be anti-dilutive. The weighted average common stock equivalents presented above do not include the effect of approximately 78,900 and 22,000 common stock equivalents for the three months ended March 31, 2013 and 2012, respectively, because their inclusion would be anti-dilutive.

7.       Borrowings

During 2011, the Company and certain of the Company’s subsidiaries as guarantors entered into an Amended and Restated Credit Agreement with various financial institutions, as amended by the first amendment to the credit agreement dated as of August 31, 2012 (collectively, the “2011 Credit Agreement”). The 2011 Credit Agreement replaced the previous Credit Agreement, dated as of June 7, 2006, and all subsequent amendments thereto, by and among the Company and the lenders therein.

The 2011 Credit Agreement consists of a senior secured credit facility in an aggregate principal amount of $450.0 million comprised of a five-year revolving credit facility (“Revolver”) under which the Company may borrow from time to time up to $247.5 million and a $202.5 million five-year term loan facility (“Term Loan”) that was funded in a single advance on the closing date of the first amendment. The 2011 Credit Agreement provides for the option to increase the revolving credit facility in an aggregate amount of up to $50 million subject to certain requirements as defined in the 2011 Credit Agreement. The proceeds of the senior secured credit facility were used to refinance existing indebtedness and will continue to be used for working capital, capital expenditures, and other corporate purposes.

8

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

The obligations under the 2011 Credit Agreement are secured pursuant to a Security Agreement with Bank of America as Administrative Agent. The Security Agreement grants Bank of America, N.A. for the ratable benefit of the lenders under the 2011 Credit Agreement, a first-priority lien, subject to permitted liens, on substantially all of the personal property assets of the Company and the subsidiary guarantors. The Revolver and Term Loan are also secured by a pledge of 100% of the voting stock or other equity interests in our domestic subsidiaries and 65% of the voting stock or other equity interests in our foreign subsidiaries.

Fees and interest on borrowings vary based on our total debt to earnings before interest, taxes, depreciation and amortization (“EBITDA”) ratio as set forth in the 2011 Credit Agreement. Interest is based on a spread over the London Interbank Offered Rate (“LIBOR”) or a spread over the base rate, as selected by the Company. The base rate is the greater of (a) the Federal Funds Rate plus 0.5%, (b) the Prime Rate and (c) except during a Eurodollar Unavailability Period, the Eurodollar Rate plus 1.0%.

The Term Loan, as amended, is subject to scheduled quarterly amortization payments equal to 4.9% of the original principal balance in 2012, which was paid as of December 31, 2012, 11.7% in 2013, 12.4% in 2014, 14.2% in 2015, 14.8% in 2016 and 42.0% in 2017, as set forth in the 2011 Credit Agreement. The maturity date for the Term Loan is August 31, 2017, at which time the outstanding principal balance and all accrued interest will be due and payable in full. All outstanding borrowings under the Revolver, as amended, will be due upon expiration of the 2011 Credit Agreement on August 31, 2017.

Under the 2011 Credit Agreement, dividends are restricted to an amount up to $50 million plus 50% of cumulative consolidated net income from the closing date of the 2011 Credit Agreement plus 50% of the net cash proceeds from equity issuances. In addition, certain acquisitions and similar transactions need to be approved by the lenders.

The 2011 Credit Agreement contains quarterly financial covenants that require us to maintain a minimum fixed charge coverage ratio of 2.25 to 1.00 and a maximum leverage ratio that varies throughout the term and was 3.25 to 1.00 as of March 31, 2013, as those ratios are defined therein, as well as a minimum net worth greater than $150 million. At March 31, 2013, we were in compliance with these financial covenants with a fixed charge coverage ratio of 3.81 to 1.00, a leverage ratio of 1.54 to 1.00, and net worth greater than $150 million. At December 31, 2012, we were also in compliance with our financial debt covenants.

The borrowing capacity under the 2011 Credit Agreement is reduced by any outstanding letters of credit and payments under the Term Loan. At March 31, 2013, outstanding letters of credit totaled $5.1 million and are primarily used as security deposits for our office facilities. As of March 31, 2013, the unused borrowing capacity under the 2011 Credit Agreement was $227.4 million. Borrowings outstanding under this credit facility at March 31, 2013 totaled $202.5 million. These borrowings carried a weighted average interest rate of 2.6%, including the effect of the interest rate swaps described below in Note 9 “Derivative Instruments and Hedging Activity.” Borrowings outstanding at December 31, 2012 were $192.5 million and carried a weighted average interest rate of 2.5%. Effective March 31, 2013, we have classified as current liabilities, the scheduled quarterly principal payments due under the Term Loan within twelve months of the balance sheet date, as we intend to make these payments with cash from operations rather than from availability under the Revolver.

8.       Restructuring Charges

We did not incur restructuring charge expense during the first quarter of 2013. As of March 31, 2013, our restructuring charge liability is $1.0 million, and primarily consists of the present value of remaining lease payments, net of estimated sublease income, for our vacated office spaces in San Francisco and Washington, D.C. The restructuring charge liability is included as a component of Accrued expenses and Deferred compensation and other liabilities.

During the first quarter of 2012, we incurred a $0.8 million pre-tax restructuring charge, primarily consisting of accelerated depreciation on leasehold improvements related to the anticipated relocation of one of our New York City office locations, which we relocated during the fourth quarter of 2012. We did not incur a lease charge related to the relocation of our New York City office space as income from our subtenant is expected to more than offset our remaining lease obligations through 2016, net of our deferred lease liability.

9

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

9.       Derivative Instruments and Hedging Activity

On March 20, 2009, we entered into an interest rate swap agreement for a notional amount of $100.0 million effective on March 31, 2009 and ending on February 23, 2012. We entered into this derivative instrument to hedge against the risk of changes in future cash flows related to changes in interest rates on $100.0 million of the total variable-rate borrowings outstanding described above in Note 7 “Borrowings.” Under the terms of the interest rate swap agreement, we received from the counterparty interest on the $100.0 million notional amount based on one-month LIBOR and we paid to the counterparty a fixed rate of 1.715%. This swap effectively converted $100.0 million of our variable-rate borrowings to fixed-rate borrowings beginning on March 31, 2009 and through February 23, 2012.

On December 8, 2011, we entered into a forward amortizing interest rate swap agreement effective on February 29, 2012 and ending on April 14, 2016. We entered into this derivative instrument to continue hedging against the interest rate risks of our variable-rate borrowings described above. The swap had an initial notional amount of $56.6 million and amortizes throughout the term. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one-month LIBOR and we pay to the counterparty a fixed rate of 0.9875%.

On May 30, 2012, we entered into an additional forward amortizing interest rate swap agreement effective on May 31, 2012 and ending on April 14, 2016. We entered into this derivative instrument to further hedge against the interest rate risks of our variable-rate borrowings described above. The swap had an initial notional amount of $37.0 million and amortizes throughout the term. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one-month LIBOR and we pay to the counterparty a fixed rate of 0.70%.

FASB ASC Topic 815, “Derivatives and Hedging,” requires companies to recognize all derivative instruments as either assets or liabilities at fair value on the balance sheet. In accordance with ASC Topic 815, we have designated these derivative instruments as cash flow hedges. As such, changes in the fair value of the derivative instruments are recorded as a component of other comprehensive income (“OCI”) to the extent of effectiveness and reclassified into interest expense upon settlement. The ineffective portion of the change in fair value of the derivative instruments is recognized in interest expense. As of March 31, 2013, it was anticipated that $0.3 million of the net losses, net of tax, currently recorded in OCI will be reclassified into earnings within the next 12 months. Our interest rate swap agreements were effective during the three months ended March 31, 2013.

The tables below set forth additional information relating to these interest rate swaps designated as cash flow hedging instruments as of March 31, 2013 and December 31, 2012.

	Fair Value (Derivative Liability)
Balance Sheet Location	March 31, 2013		December 31, 2012
Accrued expenses	$	455	$	493
Deferred compensation and other liabilities	$	365	$	439

We do not use derivative instruments for trading or other speculative purposes, and we did not have any other derivative instruments or hedging activities as of March 31, 2013. Refer to Note 11 “Other Comprehensive (Loss) Income” for additional information on our derivative instruments.

On April 4, 2013, we entered into a one-year forward amortizing interest rate swap agreement effective on March 31, 2014 and ending on August 31, 2017. We entered into this derivative instrument to further hedge against the interest rate risks of our variable-rate borrowings described above. The swap has an initial notional amount of $60.0 million and amortizes throughout the term. Under the terms of the interest rate swap agreement, we will receive from the counterparty interest on the notional amount based on one-month LIBOR and we will pay to the counterparty a fixed rate of 0.985%.

10

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

10.       Fair Value of Financial Instruments

Certain of our assets and liabilities are measured at fair value. FASB ASC Topic 820, “Fair Value Measurements and Disclosures,” defines fair value as the price that would be received to sell an asset or the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy for inputs used in measuring fair value and requires companies to maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy consists of three levels based on the objectivity of the inputs as follows:

Level 1 Inputs	Quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.
Level 2 Inputs	Quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
Level 3 Inputs	Unobservable inputs for the asset or liability, and include situations in which there is little, if any, market activity for the asset or liability.

Cash and cash equivalents are stated at cost, which approximates fair market value. The carrying values for receivables from clients, unbilled services, accounts payable, deferred revenues and other accrued liabilities reasonably approximate fair market value due to the nature of the financial instrument and the short-term maturity of these items. The carrying values of our bank borrowings reported in the Consolidated Balance Sheets approximate fair value, using level 2 inputs, since they bear interest at variable rates based on market rates as set forth in the 2011 Credit Agreement. Refer to Note 7 “Borrowings.”

The table below sets forth our fair value hierarchy for our financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2013 and December 31, 2012.

	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
March 31, 2013
Asset:
Promissory note	$	—	$	—	$	2,974	$	2,974
Liabilities:
Interest rate swaps	$	—	$	820	$	—	$	820
Deferred acquisition payments		—		—		10,542		10,542
Total liabilities	$	—	$	820	$	10,542	$	11,362
December 31, 2012
Asset:
Promissory note	$	—	$	—	$	2,907	$	2,907
Liabilities:
Interest rate swaps	$	—	$	932	$	—	$	932
Deferred acquisition payments		—		—		10,525		10,525
Total liabilities	$	—	$	932	$	10,525	$	11,457

11

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

As part of the consideration received for the sale of our AA practice on December 30, 2011, the Company received a $3.5 million promissory note payable over four years. The note will be paid to the Company in quarterly installments of approximately $0.2 million beginning in the second quarter of 2013 with a final payment of approximately $1.1 million on the maturity date in December 2015. The fair value of the note is based on the net present value of the projected cash flows using a discount rate of 14%, which accounts for the risks associated with the note. The increase in the fair value of the note during the first three months of 2013 reflects the accretion of interest income in excess of interest payments received.

The fair value of the interest rate swaps was derived using estimates to settle the interest rate swap agreements, which are based on the net present value of expected future cash flows on each leg of the swaps utilizing market-based inputs and discount rates reflecting the risks involved.

Deferred acquisition payments are included in the total purchase consideration for certain business acquisitions the Company has completed, and represent fixed future payments owed to the sellers of those businesses. The fair value of the deferred acquisition payments is based on the payment terms, which range from 1 to 2 years, and the net present value of expected cash flows using a discount rate ranging from 4% to 8%. The increase in the fair value of the deferred acquisition payments during the first three months of 2013 reflects the accretion of interest expense in excess of interest payments made.

11.       Other Comprehensive (Loss) Income

The table below sets forth the components of other comprehensive (loss) income, net of tax, for the three months ended March 31, 2013 and 2012.

	Three Months Ended March 31, 2013									Three Months Ended March 31, 2012
	Before Taxes			Tax (Expense) Benefit			Net of Taxes			Before Taxes			Tax (Expense) Benefit			Net of Taxes
Other comprehensive (loss) income:
Foreign currency translation adjustment	$	(1,048	)	$	51		$	(997	)	$	353		$	(114	)		239
Unrealized gain on cash flow hedges:
Change in fair value		(25	)		11			(14	)		(173	)		70			(103	)
Reclassification adjustments into earnings		137			(55	)		82			254			(102	)		152
Net unrealized gain		112			(44	)		68			81			(32	)		49
Other comprehensive (loss) income	$	(936	)	$	7			(929	)	$	434		$	(146	)		288

Amounts reclassified from accumulated other comprehensive loss related to our cash flow hedges are recorded to Interest expense, net of interest income.

Accumulated other comprehensive loss, net of tax, includes the following components:

	Foreign Currency Translation Adjustments			Net Unrealized Gains/(Losses) on Derivatives			Accumulated Other Comprehensive Loss
Balance, December 31, 2012	$	(805	)	$	(554	)	$	(1,359	)
Current period change		(997	)		68			(929	)
Balance, March 31, 2013	$	(1,802	)	$	(486	)	$	(2,288	)

12

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

12.       Income Taxes

The Company’s effective tax rates for the three months ended March 31, 2013 and 2012 were 41.7% and 72.1%, respectively. The effective tax rate in the first quarter of 2013 was slightly higher than the statutory rate, inclusive of state income taxes, due primarily to the impact of foreign losses with no tax benefit and certain non-deductible business expenses, partially offset by the impact of the retroactive reinstatement of the federal research and development tax credit, which was enacted during the quarter. The effective tax rate in the first quarter of 2012 was higher than the statutory rate, inclusive of state income taxes, due primarily to the impact of foreign losses with no tax benefit and certain non-deductible expenses. The foreign losses with no tax benefit and the non-deductible expenses had a larger impact on our effective tax rate in the first quarter of 2012 compared to 2013 due to the lower pretax income from continuing operations in the first quarter of 2012.

13.       Commitments, Contingencies and Guarantees

Litigation

Qui Tam Action

On December 9, 2009, plaintiff, Associates Against Outlier Fraud, filed a first amended qui tam complaint against Huron Consulting Group Inc. and others under the federal and New York state False Claims Act (“FCA”) in the United States District Court for the Southern District of New York. The federal and state FCA authorize private individuals (known as “relators”) to sue on behalf of the government (known as “qui tam” actions) alleging that false or fraudulent claims were knowingly submitted to the government. Once a qui tam action is filed, the government may elect to intervene in the action. If the government declines to intervene, the relator may proceed with the action. Under the federal and state FCA, the government may recover treble damages and civil penalties (civil penalties of up to $11,000 per violation under the federal FCA and $12,000 per violation under the state FCA). On January 6, 2010, the United States declined to intervene in the lawsuit. After the Court granted Huron’s motion to dismiss without prejudice, on September 29, 2010, the relator filed a second amended complaint alleging that Huron and others caused St. Vincent Catholic Medical Center to receive more than $30 million in inflated outlier payments under the Medicare and Medicaid programs in violation of the federal and state FCA and seeking to recover an unspecified amount of civil penalties. On March 8, 2013, the Court granted Huron’s motion for summary judgment and dismissed relator’s second amended complaint in its entirety with prejudice. As a result, we reversed the charge of $1.2 million relating to settlement discussions which we recorded in the second quarter of 2012, in accordance with FASB ASC Topic 450, “Contingencies.” The relator filed an appeal on April 2, 2013. On April 8, 2013, Huron filed an appeal of an earlier denial of a motion to dismiss filed by Huron which argued that relator’s action was barred because, under the FCA jurisdictional bar, the action was based on publicly disclosed information and relator cannot qualify as an original source. We continue to believe that the claims are without merit and intend to vigorously defend ourselves in this matter.

From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. As of the date of this Quarterly Report on Form 10-Q, we are not a party to or threatened with any other litigation or legal proceeding that, in the current opinion of management, could have a material adverse effect on our financial position or results of operations. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results.

Guarantees and Indemnification

Guarantees in the form of letters of credit totaling $5.1 million were outstanding at both March 31, 2013 and December 31, 2012 to support certain office lease obligations as well as Middle East performance and bid bonds.

To the extent permitted by law, our bylaws and articles of incorporation require that we indemnify our officers and directors against judgments, fines and amounts paid in settlement, including attorneys’ fees, incurred in connection with civil or criminal action or proceedings, as it relates to their services to us if such person acted in good faith. Although there is no limit on the amount of indemnification, we may have recourse against our insurance carrier for certain payments made.

13

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

14.       Segment Information

Segments are defined by FASB ASC Topic 280, “Segment Reporting,” as components of a company in which separate financial information is available and is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. In the first quarter of 2013, the Company reorganized its internal financial reporting structure. Under the new structure, the Company began reporting information as five operating segments: Huron Healthcare; Huron Legal; Huron Education and Life Sciences; Huron Financial; and All Other. Our chief operating decision maker manages the business under these five operating segments.

Under this new internal financial reporting structure, the former Health and Education Consulting segment became two separate segments: Huron Healthcare and Huron Education and Life Sciences. These practices continue to share a significant number of academic medical center clients and will continue to closely collaborate in the market. The Legal Consulting segment is now referred to as Huron Legal and the Financial Consulting segment is now referred to as Huron Financial. The structure of the Legal Consulting and Financial Consulting segments did not change. In addition, certain immaterial practices which were historically part of our Health and Education Consulting segment were combined and disclosed in our All Other segment. While our consolidated results have not been impacted, we have restated our historical segment information for consistent presentation.

• Huron Healthcare

Our Huron Healthcare segment provides consulting services to national and regional integrated health systems, physician practices, community hospitals, managed care organizations, and academic medical centers. This segment provides consulting services related to hospital or healthcare organization performance improvement, revenue cycle improvement, clinical quality and care variation, labor productivity, non-labor cost management, information technology, patient flow improvement and physician practice management.

• Huron Legal

Our Huron Legal segment provides advisory and business services to assist law departments of major global corporations and law firms with their strategy, organizational design and development, operational efficiency, and cost effectiveness. These results-driven services help reduce the amounts they spend on legal services and enhance client service. Our expertise focuses on strategic and management consulting, cost management, and technology and information management including matter management, records management, digital evidence, document review and discovery services.

• Huron Education and Life Sciences

Our Huron Education and Life Science segment provides consulting services to universities, research institutions, healthcare organizations, academic medical centers, and pharmaceutical, medical device manufacturer and biotechnology companies. We develop and implement performance improvement, technology, and research enterprise solutions to help clients address challenges relating to financial management, strategy, operational and organizational effectiveness, research administration, and regulatory compliance.

• Huron Financial

Our Huron Financial segment provides financial advisory, restructuring and turnaround, interim management, valuation, forensic and litigation, and operational improvement consulting services to companies in transition, boards of directors and investors and lenders. Our consultants provide senior level involvement and extensive industry experience to drive results. Our experienced leadership, management depth and flexible staffing model allow us to efficiently lead projects ranging from middle market to large company assignments. We draw on career experience gathered from operations, lending, investment banking, portfolio and asset management, public accounting, and management consulting to provide practical business solutions.

• All Other

Our All Other segment consists of any lines of business not managed by our other four operating segments. In 2013 and 2012, the All Other segment consisted of our foreign healthcare and strategic consulting operations based in the Middle East.

14

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

Segment operating income consists of the revenues generated by a segment, less the direct costs of revenue and selling, general and administrative costs that are incurred directly by the segment. Unallocated corporate costs include costs related to administrative functions that are performed in a centralized manner that are not attributable to a particular segment. These administrative function costs include costs for corporate office support, certain office facility costs, costs relating to accounting and finance, human resources, legal, marketing, information technology and Company-wide business development functions, as well as costs related to overall corporate management.

The table below sets forth information about our operating segments for the three months ended March 31, 2013 and 2012, along with the items necessary to reconcile the segment information to the totals reported in the accompanying Consolidated Financial Statements.

	Three Months Ended March 31,
	2013			2012
Huron Healthcare:
Revenues	$	78,745		$	63,465
Operating income	$	31,161		$	15,838
Segment operating income as a percent of segment revenues		39.6	%		25.0	%
Huron Legal:
Revenues	$	40,944		$	41,383
Operating income	$	2,938		$	9,511
Segment operating income as a percent of segment revenues		7.2	%		23.0	%
Huron Education and Life Sciences:
Revenues	$	35,726		$	27,676
Operating income	$	9,352		$	6,458
Segment operating income as a percent of segment revenues		26.2	%		23.3	%
Huron Financial:
Revenues	$	8,582		$	5,849
Operating income	$	3,379		$	233
Segment operating income as a percent of segment revenues		39.4	%		4.0	%
All Other:
Revenues	$	39		$	264
Operating loss	$	(172	)	$	(799	)
Segment operating loss as a percent of segment revenues		N/M			N/M
Total Company:
Revenues	$	164,036		$	138,637
Reimbursable expenses		15,336			13,796
Total revenues and reimbursable expenses	$	179,372		$	152,433
Statements of Earnings reconciliation:
Segment operating income	$	46,658		$	31,241
Charges not allocated at the segment level:
Other selling, general and administrative expenses		20,536			22,951
Depreciation and amortization expense		4,779			4,653
Other expense, net		1,850			1,533
Income from continuing operations before income tax expense	$	19,493		$	2,104

N/M - Not meaningful

15

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

	March 31, 2013		December 31, 2012
Segment Assets:
Huron Healthcare	$	78,050	$	60,288
Huron Legal		44,973		51,594
Huron Education and Life Sciences		31,985		31,129
Huron Financial		5,394		1,462
All Other		41		50
Unallocated assets (1)		615,632		643,377
Total assets	$	776,075	$	787,900

(1) Goodwill and intangible assets are included in unallocated assets, as management does not evaluate these items at the segment level when assessing segment performance or allocating resources.

At both March 31, 2013 and December 31, 2012, no single client accounted for greater than 10% of our combined receivables and unbilled services balances. No single client generated greater than 10% of our consolidated revenues during the three months ended March 31, 2013 and 2012.

16

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

In this Quarterly Report on Form 10-Q, unless the context otherwise requires, the terms “Huron,” “Company,” “we,” “us” and “our” refer to Huron Consulting Group Inc. and its subsidiaries.

Statements in this Quarterly Report on Form 10-Q, including the information incorporated by reference herein, that are not historical in nature, including those concerning the Company’s current expectations about its future requirements and needs, are “forward-looking” statements as defined in Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the Private Securities Litigation Reform Act of 1995. Forward-looking statements are identified by words such as “may,” “should,” “expects,” “provides,” “anticipates,” “assumes,” “can,” “meets,” “could,” “intends,” “might,” “predicts,” “seeks,” “would,” “believes,” “estimates,” “plans” or “continues.” These forward-looking statements reflect our current expectation about our future requirements and needs, results, levels of activity, performance, or achievements, including, without limitation, current expectations with respect to, among other factors, utilization rates, billing rates, and the number of revenue-generating professionals; that we are able to expand our service offerings; that we successfully integrate the businesses we acquire; and that existing market conditions continue to trend upward. These statements involve known and unknown risks, uncertainties and other factors, including, among others, those described under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2012 that may cause actual results, levels of activity, performance or achievements to be materially different from any anticipated results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. We disclaim any obligation to update or revise any forward-looking statements as a result of new information or future events, or for any other reason.

OVERVIEW

Our Business

We are a leading provider of operational and financial consulting services. We help clients in diverse industries improve performance, reduce costs, leverage technology, process and review large amounts of complex data, address regulatory changes, recover from distress and stimulate growth. Our professionals employ their expertise in administration, management, finance and operations to provide our clients with specialized analyses and customized advice and solutions that are tailored to address each client’s particular challenges and opportunities to deliver sustainable and measurable results. We provide consulting services to a wide variety of both financially sound and distressed organizations, including healthcare organizations, leading academic institutions, Fortune 500 companies, governmental entities and law firms. We have worked with more than 95 of the top 100 research universities, more than 400 corporate general counsel, and more than 385 hospitals and academic medical centers.

We provide our services through five operating segments: Huron Healthcare, Huron Legal, Huron Education and Life Sciences, Huron Financial and All Other.

• Huron Healthcare

Our Huron Healthcare segment provides consulting services to national and regional integrated health systems, physician practices, community hospitals, managed care organizations, and academic medical centers. This segment provides consulting services related to hospital or healthcare organization performance improvement, revenue cycle improvement, clinical quality and care variation, labor productivity, non-labor cost management, information technology, patient flow improvement and physician practice management.

• Huron Legal

Our Huron Legal segment provides advisory and business services to assist law departments of major global corporations and law firms with their strategy, organizational design and development, operational efficiency, and cost effectiveness. These results-driven services help reduce the amounts they spend on legal services and enhance client service. Our expertise focuses on strategic and management consulting, cost management, and technology and information management including matter management, records management, digital evidence, document review and discovery services.

• Huron Education and Life Sciences

Our Huron Education and Life Sciences segment provides consulting services to universities, research institutions, healthcare organizations, academic medical centers, and pharmaceutical, medical device manufacturer and biotechnology companies. We develop and implement performance improvement, technology, and research enterprise solutions to help clients address challenges relating to financial management, strategy, operational and organizational effectiveness, research administration, and regulatory compliance.

17

• Huron Financial

Our Huron Financial segment provides financial advisory, restructuring and turnaround, interim management, valuation, forensic and litigation, and operational improvement consulting services to companies in transition, boards of directors and investors and lenders. Our consultants provide senior level involvement and extensive industry experience to drive results. Our experienced leadership, management depth and flexible staffing model allow us to efficiently lead projects ranging from middle market to large company assignments. We draw on career experience gathered from operations, lending, investment banking, portfolio and asset management, public accounting, and management consulting to provide practical business solutions.

• All Other

Our All Other segment consists of any lines of business not managed by our other four operating segments. In 2013 and 2012, the All Other segment consisted of our foreign healthcare and strategic consulting operations based in the Middle East.

How We Generate Revenues

A large portion of our revenues is generated by our full-time consultants who provide consulting services to our clients and are billable to our clients based on the number of hours worked. A smaller portion of our revenues is generated by our other professionals, also referred to as full-time equivalents, all of whom work variable schedules as needed by our clients. Other professionals include specialized finance and operational consultants and our document review and electronic data discovery groups, as well as full-time employees who provide software support and maintenance services to our clients. Our document review and electronic data discovery groups generate revenues primarily based on number of hours worked and units produced, such as pages reviewed or amount of data processed. We translate the hours that these other professionals work on client engagements into a full-time equivalent measure that we use to manage our business. We refer to our full-time consultants and other professionals collectively as revenue-generating professionals.

Revenues generated by our full-time consultants are primarily driven by the number of consultants we employ and their utilization rates, as well as the billing rates we charge our clients. Revenues generated by our other professionals, or full-time equivalents, are largely dependent on the number of consultants we employ, their hours worked and billing rates charged, as well as the number of pages reviewed and amount of data processed in the case of our document review and electronic data discovery groups, respectively.

We generate the majority of our revenues from providing professional services under four types of billing arrangements: time-and-expense, fixed-fee (including software license revenue), performance-based and support and maintenance for the software we deploy.

Time-and-expense billing arrangements require the client to pay based on either the number of hours worked, the number of pages reviewed, or the amount of data processed by our revenue-generating professionals at agreed upon rates. We recognize revenues under time-and-expense billing arrangements as the related services are rendered. Time-and-expense engagements represented 44.9% and 46.7% of our revenues in the three months ended March 31, 2013 and 2012, respectively.

In fixed-fee billing arrangements, we agree to a pre-established fee in exchange for a pre-determined set of professional services, which may include the deployment of our proprietary software. We set the fees based on our estimates of the costs and timing for completing the engagements. It is the client’s expectation in these engagements that the pre-established fee will not be exceeded except in mutually agreed upon circumstances. We generally recognize revenues under fixed-fee billing arrangements using a proportionate performance approach, which is based on our estimates of work completed to-date versus the total services to be provided under the engagement.

We also generate revenues from licensing two types of proprietary software to clients. Licenses for our revenue cycle management software are sold only as a component of our consulting projects and the services we provide are essential to the functionality of the software. Therefore, revenues from the revenue cycle management software licenses are recognized over the term of the related consulting services contract in accordance with FASB ASC Topic 605-35. License revenue from our research administration and compliance software is recognized in accordance with FASB ASC Topic 985-605, generally in the month in which the software is delivered.

18

For the three months ended March 31, 2013 and 2012, fixed-fee engagements (including software license revenue) represented approximately 40.3% and 38.5%, respectively, of our revenues.

In performance-based fee billing arrangements, fees are tied to the attainment of contractually defined objectives. We enter into performance-based engagements in essentially two forms. First, we generally earn fees that are directly related to the savings formally acknowledged by the client as a result of adopting our recommendations for improving operational and cost effectiveness in the areas we review. Second, we have performance-based engagements in which we earn a success fee when and if certain pre-defined outcomes occur. Often, performance-based fees supplement our time-and-expense or fixed-fee engagements. We do not recognize revenues under performance-based billing arrangements until all related performance criteria are met. Performance-based fee revenues represented 11.5% and 11.2% of our revenues in the three months ended March 31, 2013 and 2012, respectively. Performance-based fee engagements may cause significant variations in quarterly revenues and operating results depending on the timing of achievement of the performance-based criteria.

Clients that have purchased one of our software licenses can pay an annual fee for software support and maintenance. Annual support and maintenance fee revenue is recognized ratably over the support period, which is generally one year. These fees are billed in advance and included in deferred revenues until recognized. Support and maintenance revenues represented 3.3% and 3.6% of our revenues in the three months ended March 31, 2013 and 2012, respectively.

Our quarterly results are impacted principally by our full-time consultants’ utilization rate, the billing rate we charge our clients, the number of our revenue-generating professionals who are available to work and the amount of performance-based fees recognized, which often vary significantly between quarters. Our utilization rate can be negatively affected by increased hiring because there is generally a transition period for new professionals that results in a temporary drop in our utilization rate. Our utilization rate can also be affected by seasonal variations in the demand for our services from our clients. For example, during the third and fourth quarters of the year, vacations taken by our clients can result in the deferral of activity on existing and new engagements, which would negatively affect our utilization rate. The number of business work days is also affected by the number of vacation days taken by our consultants and holidays in each quarter. We typically have fewer business work days available in the fourth quarter of the year, which can impact revenues during that period.

Time-and-expense engagements do not provide us with a high degree of predictability as to performance in future periods. Unexpected changes in the demand for our services can result in significant variations in utilization and revenues and present a challenge to optimal hiring and staffing. Moreover, our clients typically retain us on an engagement-by-engagement basis, rather than under long-term recurring contracts. The volume of work performed for any particular client can vary widely from period to period.

Business Strategy, Opportunities and Challenges

Our primary strategy is to meet the needs of our clients by providing a balanced portfolio of service offerings and capabilities, so that we can adapt quickly and effectively to emerging opportunities in the marketplace. To achieve this, we have entered into select acquisitions of complementary businesses and continue to hire highly qualified professionals.

To expand our business, we will remain focused on growing our existing relationships and developing new relationships, execute our managing director compensation plan to attract and retain senior practitioners, continue to promote and provide an integrated approach to service delivery, broaden the scope of our existing services, and acquire complementary businesses. We will regularly evaluate the performance of our practices to ensure our investments meet these objectives. Furthermore, we intend to enhance our visibility in the marketplace by refining our overarching messaging and value propositions for the organization as well as each practice. We will continue to focus on reaching our client base through clear, concise, endorsed messages.

CRITICAL ACCOUNTING POLICIES

Management’s discussion and analysis of financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with GAAP. We review our financial reporting and disclosure practices and accounting policies to ensure that our financial reporting and disclosures provide accurate information relative to the current economic and business environment. The preparation of financial statements in conformity with GAAP requires management to make assessments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements,

19

as well as the reported amounts of revenues and expenses during the reporting period. Critical accounting policies are those policies that we believe present the most complex or subjective measurements and have the most potential to impact our financial position and operating results. While all decisions regarding accounting policies are important, we believe that there are four accounting policies that could be considered critical. These critical accounting policies relate to revenue recognition, allowances for doubtful accounts and unbilled services, carrying values of goodwill and other intangible assets, and valuation of net deferred tax assets. For a detailed discussion of these critical accounting policies, see “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies” in our Annual Report on Form 10-K for the year ended December 31, 2012. Below is an update to our critical accounting policy relating to the carrying values of goodwill and other intangible assets. There have been no material changes to our other critical accounting policies during the first three months of 2013.

Carrying Values of Goodwill and Other Intangible Assets

During the first quarter of 2013, we changed our internal financial reporting structure. Under the new structure, our former Health and Education Consulting segment became two separate segments: Huron Healthcare and Huron Education and Life Sciences. In addition, certain immaterial practices which were historically part of our Health and Education Consulting segment were combined and disclosed in our All Other segment. The Legal Consulting segment is now referred to as Huron Legal and the Financial Consulting segment is now referred to as Huron Financial. The structure of the Legal Consulting and Financial Consulting segments did not change. As a result of these changes, we now have five reporting segments, which are the same as our operating segments and reporting units.

In accordance with ASC 350, “Intangibles – Goodwill and Other”, we reassigned the goodwill balance of the Health and Education Consulting segment using the relative fair value approach based on an evaluation of expected future discounted cash flows. Based on this relative fair value analysis, we reassigned $355.9 million of goodwill to Huron Healthcare and $94.6 million of goodwill to Huron Education and Life Sciences.

In conjunction with the goodwill reassignment, we performed the first step of the goodwill impairment test for the goodwill balances within our Huron Healthcare and Huron Education and Life Sciences reporting units as of January 2, 2013. Based on the result of the first step of the goodwill impairment test, we determined that the fair values of our Huron Healthcare and Huron Education and Life Sciences reporting units exceeded their carrying values. Since the fair values of both reporting units exceeded their carrying values, the second step of the goodwill impairment test was not necessary.

In estimating the fair value of our Huron Healthcare and Huron Education and Life Sciences reporting units, we relied on a combination of the income approach and the market approach, utilizing the guideline company method, with a fifty-fifty weighting. For companies providing services similar to those provided by us, the income and market approaches will generally provide the most reliable indications of value because the value of such companies is dependent on their ability to generate earnings.

In the income approach, we utilized a discounted cash flow analysis, which involved estimating the expected after-tax cash flows that will be generated by our reporting units and then discounting those cash flows to present value reflecting the relevant risks associated with the reporting units and the time value of money. This approach requires the use of significant estimates and assumptions, including long-term projections of future cash flows, market conditions, discount rates reflecting the risk inherent in future cash flows, revenue growth, perpetual growth rates and profitability, among others. In estimating future cash flows, we relied on an internally generated six-year forecast. For periods after the six-year forecast, we assumed a 3.5% long-term annual revenue growth rate. Our forecast is based on our historical experience, current backlog, expected market demand, and other industry information. Our discounted cash flow analysis assumed a 13% weighted average cost of capital (“WACC”) discount rate for each reporting unit.

In the market approach, we utilized the guideline company method, which involved calculating valuation multiples based on operating data from guideline publicly traded companies. Multiples derived from guideline companies provide an indication of how much a knowledgeable investor in the marketplace would be willing to pay for a company. These multiples were then adjusted for factors similar to those used in a discounted cash flow analysis and applied to the operating data for our reporting units to arrive at an indication of value.

Determining the fair value of a reporting unit requires us to make significant judgments, estimates and assumptions. While we believe that the estimates and assumptions underlying our valuation methodology are reasonable, these estimates and assumptions could have a significant impact on whether or not an impairment charge is recognized and also the magnitude of any such charge. The results of an impairment analysis are as of a point in time. There is no assurance that the actual

20

future earnings or cash flows of our reporting units will not differ significantly from our projections. We will monitor any changes to our assumptions and will evaluate goodwill as deemed warranted during future periods. Any significant decline in our operations could result in goodwill impairment charges.

RESULTS OF OPERATIONS

The following table sets forth, for the periods indicated, selected segment and consolidated operating results and other operating data. Segment operating income consists of the revenues generated by a segment, less the direct costs of revenue and selling, general and administrative costs that are incurred directly by the segment. Unallocated costs include corporate costs related to administrative functions that are performed in a centralized manner that are not attributable to a particular segment. During the first quarter of 2013, we changed our internal financial reporting structure. Under the new structure, our former Health and Education Consulting segment became two separate segments: Huron Healthcare and Huron Education and Life Sciences. In addition, certain immaterial practices which were historically part of our Health and Education Consulting segment were combined and disclosed in our All Other segment. The Legal Consulting segment is now referred to as Huron Legal and the Financial Consulting segment is now referred to as Huron Financial. The structure of the Legal Consulting and Financial Consulting segments did not change. As a result of these changes, we now have five reporting segments, which are the same as our operating segments.

See Note 4 “Discontinued Operations” of this Quarterly Report on Form 10-Q for information related to our discontinued operations.

21

	Three Months Ended March 31,
	2013			2012
Segment and Consolidated Operating Results
(in thousands):
Revenues and reimbursable expenses:
Huron Healthcare	$	78,745		$	63,465
Huron Legal		40,944			41,383
Huron Education and Life Sciences		35,726			27,676
Huron Financial		8,582			5,849
All Other		39			264
Total revenues		164,036			138,637
Total reimbursable expenses		15,336			13,796
Total revenues and reimbursable expenses	$	179,372		$	152,433
Operating income (loss):
Huron Healthcare	$	31,161		$	15,838
Huron Legal		2,938			9,511
Huron Education and Life Sciences		9,352			6,458
Huron Financial		3,379			233
All Other		(172	)		(799	)
Total segment operating income		46,658			31,241
Operating expenses not allocated to segments		25,315			27,604
Total operating income	$	21,343		$	3,637
Other Operating Data (excluding All Other):
Number of full-time billable consultants (at period end) (1):
Huron Healthcare (5)		870			809
Huron Legal		151			118
Huron Education and Life Sciences		436			328
Huron Financial		62			67
Total (5)		1,519			1,322
Average number of full-time billable consultants (for the period) (1):
Huron Healthcare (5)		863			788
Huron Legal		146			116
Huron Education and Life Sciences		430			322
Huron Financial		62			68
Total (5)		1,501			1,294
Full-time billable consultant utilization rate (2):
Huron Healthcare (5)		85.6	%		83.2	%
Huron Legal		52.0	%		70.7	%
Huron Education and Life Sciences		70.0	%		70.8	%
Huron Financial		84.7	%		59.6	%
Total (5)		77.9	%		77.8	%

22

	Three Months Ended March 31,
	2013		2012
Other Operating Data (Continued):
Full-time billable consultant average billing rate per hour (3):
Huron Healthcare (5)	$	205	$	192
Huron Legal	$	222	$	234
Huron Education and Life Sciences	$	206	$	212
Huron Financial	$	331	$	275
Total (5)	$	212	$	203
Revenue per full-time billable consultant (in thousands):
Huron Healthcare (5)	$	85	$	74
Huron Legal	$	53	$	80
Huron Education and Life Sciences	$	70	$	73
Huron Financial	$	135	$	81
Total (5)	$	79	$	74
Average number of full-time equivalents (for the period) (4):
Huron Healthcare (5)		56		62
Huron Legal		1,089		897
Huron Education and Life Sciences		39		28
Huron Financial		2		2
Total (5)		1,186		989
Revenue per full-time equivalents (in thousands):
Huron Healthcare (5)	$	104	$	88
Huron Legal	$	31	$	36
Huron Education and Life Sciences	$	151	$	145
Huron Financial	$	149	$	187
Total (5)	$	38	$	43

(1) Consists of our full-time professionals who provide consulting services and generate revenues based on the number of hours worked.

(2) Utilization rate for our full-time billable consultants is calculated by dividing the number of hours all our full-time billable consultants worked on client assignments during a period by the total available working hours for all of these consultants during the same period, assuming a forty-hour work week, less paid holidays and vacation days.

(3) Average billing rate per hour for our full-time billable consultants is calculated by dividing revenues for a period by the number of hours worked on client assignments during the same period.

(4) Consists of consultants who work variable schedules as needed by our clients, as well as other professionals who generate revenues primarily based on number of hours worked and units produced, such as pages reviewed and data processed. Also includes full-time employees who provide software support and maintenance services to our clients.

(5) Effective January 1, 2013, a group within the Huron Healthcare segment that provides post-implementation services that was previously classified as full-time equivalents will be classified as full-time billable consultants due to the evolving nature of the services that they offer. Prior periods have been restated to reflect this change.

Non-GAAP Measures

We also assess our results of operations using certain non-GAAP financial measures. These non-GAAP financial measures differ from GAAP because the non-GAAP financial measures we calculate to measure adjusted EBITDA, adjusted net income from continuing operations and adjusted diluted earnings per share exclude a number of items required by GAAP, each discussed below. These non-GAAP financial measures should be considered in addition to, and not as a substitute for or superior to, any measure of performance, cash flows or liquidity prepared in accordance with GAAP. Our non-GAAP financial measures may be defined differently from time to time and may be defined differently than similar terms used by other companies, and accordingly, care should be exercised in understanding how we define our non-GAAP financial measures.

23

Our management uses the non-GAAP financial measures to gain an understanding of our comparative operating performance, for example when comparing such results with previous periods or forecasts. These non-GAAP financial measures are used by management in their financial and operating decision making because management believes they reflect our ongoing business in a manner that allows for meaningful period-to-period comparisons. Management also uses these non-GAAP financial measures when publicly providing our business outlook, for internal management purposes, and as a basis for evaluating potential acquisitions and dispositions. We believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating Huron’s current operating performance and future prospects in the same manner as management does and in comparing in a consistent manner Huron’s current financial results with Huron’s past financial results.

The reconciliations of these financial measures from GAAP to non-GAAP are as follows (in thousands):

	Three Months Ended March 31,
	2013			2012
Revenues	$	164,036		$	138,637
Net income from continuing operations	$	11,369		$	587
Add back:
Income tax expense		8,124			1,517
Interest and other expenses		1,850			1,533
Depreciation and amortization		5,437			5,795
Earnings before interest, taxes, depreciation and amortization (EBITDA)		26,780			9,432
Add back:
Restatement related expenses		—			1,505
Restructuring charges		—			830
Litigation settlement gain		(1,150	)		—
Adjusted EBITDA	$	25,630		$	11,767
Adjusted EBITDA as a percentage of revenues		15.6	%		8.5	%
	Three Months Ended March 31,
	2013			2012
Net income from continuing operations	$	11,369		$	587
Weighted average shares – diluted		22,487			22,164
Diluted earnings per share from continuing operations	$	0.51		$	0.03
Add back:
Amortization of intangible assets		1,456			1,619
Restatement related expenses		—			1,505
Restructuring charges		—			830
Litigation settlement gain		(1,150	)		—
Tax effect		(122	)		(1,582	)
Total adjustments, net of tax		184			2,372
Adjusted net income from continuing operations	$	11,553		$	2,959
Adjusted diluted earnings per share from continuing operations	$	0.51		$	0.13

These non-GAAP financial measures include adjustments for the following items:

Restatement related expenses: We have incurred significant expenses related to our 2009 financial statement restatement. We have excluded the effect of these restatement related expenses from our non-GAAP measures as a means to provide comparability with periods that were not impacted by the restatement related expenses.

24

Restructuring charges: We have incurred charges due to the restructuring of various parts of our business. These restructuring charges have primarily consisted of severance charges, costs associated with office space reductions including the accelerated depreciation of certain leasehold improvements, and the write-off of certain impaired intangible assets. We have excluded the effect of the restructuring charges from our non-GAAP measures as a means to provide comparability with periods that were not impacted by a restructuring charge. Additionally, the amount of each restructuring charge is significantly affected by the timing and size of the restructured business or component of a business.

Litigation settlement gain: We have excluded the effects of the litigation settlement gain because its exclusion permits comparability with periods that were not impacted by these charges.

Amortization of intangible assets: We have excluded the effect of amortization of intangible assets from the non-GAAP measures presented above. Amortization of intangibles is inconsistent in its amount and frequency and is significantly affected by the timing and size of our acquisitions.

Tax effect: The non-GAAP income tax adjustment reflects the incremental tax rate applicable to the non-GAAP adjustments.

Income tax expense, Interest and other expenses, Depreciation and amortization: We have excluded the effects of income tax expense, interest and other expenses, and depreciation and amortization in the calculation of EBITDA as these are customary exclusions as defined by the calculation of EBITDA to arrive at meaningful earnings from core operations excluding the effect of such items.

Three Months Ended March 31, 2013 Compared to Three Months Ended March 31, 2012

Revenues

Revenues increased $25.4 million, or 18.3%, to $164.0 million for the first quarter of 2013 from $138.6 million for the first quarter of 2012.

The overall increase was attributable to a $22.6 million increase in revenue from our full-time billable consultants and a $2.8 million increase in revenue from our full-time equivalents. The increase in full-time billable consultant revenues was driven by increases in the average number of billable consultants, our average billing rate and our consultant utilization rate. The increase primarily reflected strengthened demand for our services in the Huron Healthcare, Huron Education and Life Sciences and Huron Financial segments, partially offset by a decrease in demand for our services in the Huron Legal segment. The increase in full-time equivalent revenue was primarily attributable to an increase in the average number of full-time equivalents, partially offset by a decrease in revenues per full-time equivalent. Revenue attributable to full-time equivalents primarily reflected increased use of contractors in the Huron Education and Life Sciences and Huron Healthcare segments and increased demand for our document review and discovery services in the Huron Legal segment.

Total Direct Costs

Our total direct costs increased $8.9 million, or 9.1%, to $106.8 million in the three months ended March 31, 2013 from $97.9 million in the three months ended March 31, 2012. The increase was primarily related to a $10.7 million increase in salaries, bonuses and related expenses for our revenue-generating professionals, partially offset by a $1.0 million decrease in contractor expense, a $0.5 million decrease in intangible asset amortization expense and a $0.3 million decrease in technology expense. As a percentage of revenues, our total direct costs decreased to 65.1% during the first quarter of 2013 compared to 70.6% during the first quarter of 2012. This primarily reflected the decrease in contractor expense and revenue growth that outpaced the increase in salaries, bonuses and related expenses for our revenue-generating professionals during the first quarter of 2013.

Total direct costs for the three months ended March 31, 2013 included $3.6 million of share-based compensation expense and $0.7 million of amortization expense for intangible assets and software development costs, primarily representing customer-related assets and software acquired in business combinations. Total direct costs for the three months ended March 31, 2012 included $3.8 million of share-based compensation expense and $1.1 million of intangible asset amortization expense. The decrease in intangible asset amortization is primarily attributable to certain intangible assets that became fully amortized during the third quarter of 2012.

25

Operating Expenses

Selling, general and administrative expenses increased $2.2 million, or 7.3%, to $32.3 million in the first quarter of 2013 from $30.1 million in the first quarter of 2012. This increase was primarily related to a $2.1 million increase in salaries, bonuses and related expenses for our support personnel. As a percentage of revenues, selling, general and administrative expenses decreased to 19.7% during the first quarter of 2013 compared to 21.7% during the first quarter of 2012. This decrease reflected flat non-personnel related costs while revenue increased during the first quarter of 2013.

We did not incur restructuring or restatement related expenses during the first three months of 2013. During the first three months of 2012 we incurred $0.8 million of restructuring expense and $1.5 million of restatement related expenses.

We recorded a $1.2 million litigation settlement gain during the first quarter of 2013. During the second quarter of 2012, we conducted preliminary settlement discussions with the relator in the qui tam action discussed in “Legal Proceedings” and in Note 13 “Commitments, Contingencies and Guarantees”, and as a result we recorded a charge of $1.2 million, in accordance with FASB ASC Topic 450, “Contingencies.” On March 8, 2013, the Court granted Huron’s motion for summary judgment and dismissed relator’s second amended complaint in its entirety with prejudice. As a result, we reversed the charge of $1.2 million taken during 2012.

Depreciation and amortization expense increased by $0.1 million to $4.8 million in the three months ended March 31, 2013 from $4.7 million in the three months ended March 31, 2012. Non-direct intangible asset amortization relates to non-competition agreements, trade names and certain customer relationships acquired in connection with our acquisitions.

Operating Income

Operating income increased $17.7 million to $21.3 million in the first quarter of 2013 from $3.6 million in the first quarter of 2012. Operating margin, which is defined as operating income expressed as a percentage of revenues, increased to 13.0% in the three months ended March 31, 2013 compared to 2.6% in the three months ended March 31, 2012. This increase is primarily attributable to the decreases in contractor expense, technology expense, restatement related expenses and restructuring expense, as well as the decrease in salaries, bonuses and related expenses for our revenue-generating professionals and non-personnel related selling, general and administrative expenses as a percentage of revenues. The operating margin in the first quarter of 2013 was also positively impacted by the litigation settlement gain in the period.

Other Expense, Net

Other expense, net increased by $0.4 million to $1.9 million in the first quarter of 2013 from $1.5 million in the first quarter of 2012. Interest expense was $1.9 million in both 2013 and 2012. The increase in other income, net was the result of improved performance of the investments used to fund our deferred compensation liability.

Income Tax Expense

For the first quarter of 2013, we recognized income tax expense from continuing operations of $8.1 million on income from continuing operations of $19.5 million. For the first quarter of 2012, we recognized income tax expense from continuing operations of $1.5 million on income from continuing operations of $2.1 million. Our effective tax rate for the first quarter of 2013 was 41.7% compared with 72.1% in 2012. The effective tax rate in the first quarter of 2013 was slightly higher than the statutory rate, inclusive of state income taxes, due primarily to the impact of foreign losses with no tax benefit and certain non-deductible business expenses, partially offset by the impact of the retroactive reinstatement of the federal research and development tax credit, which was enacted during the quarter. The effective benefit rate in the first quarter of 2012 was higher than the statutory rate, inclusive of state income taxes, due primarily to the impact of foreign losses with no tax benefit and certain non-deductible business expenses. The foreign losses with no tax benefit and the non-deductible expenses had a larger impact on our effective tax rate in the first quarter of 2012 compared to 2013 due to the lower pretax income from continuing operations in the first quarter of 2012.

Net Income from Continuing Operations

Net income from continuing operations was $11.4 million for the three months ended March 31, 2013 compared to net income from continuing operations of $0.6 million for the same period last year. The increase in net income from continuing operations was primarily due to the increase in operating income, as discussed above, partially offset by the corresponding increase in income tax expense and the slight increase in other expense, net. As a result of the increase in net income from continuing operations, diluted earnings per share from continuing operations for the first quarter of 2013 was $0.51 compared to diluted earnings per share from continuing operations of $0.03 for the first quarter of 2012.

26

Discontinued Operations

Net loss from discontinued operations was less than $0.1 million in the first quarter of 2013, compared to net income from discontinued operations of $0.3 million in the first quarter of 2012. See Note 4 “Discontinued Operations” of this Quarterly Report on Form 10-Q for further information about our discontinued operations.

EBITDA and Adjusted EBITDA

EBITDA increased $17.4 million to $26.8 million for the three months ended March 31, 2013 from $9.4 million for the three months ended March 31, 2012. Adjusted EBITDA increased $13.8 million to $25.6 million in the first quarter of 2013 from $11.8 million in the first quarter of 2012. The increases in both EBITDA and Adjusted EBITDA were primarily driven by the increases in segment operating income of our Huron Healthcare, Huron Education and Life Sciences and Huron Financial segments, partially offset by the decrease in segment operating income of our Huron Legal segment, as discussed below in Segment Results. The increase in EBITDA outpaced the increase in Adjusted EBITDA due to the decreases in restatement related expenses and restructuring expense, as well as the litigation settlement gain, all of which are excluded from the computation of Adjusted EBITDA.

Adjusted Net Income from Continuing Operations

Adjusted net income from continuing operations was $11.6 million in the first quarter of 2013 compared to $3.0 million in the first quarter of 2012. The increase was primarily attributable to the increase in net income from continuing operations, partially offset by the decreases in restatement related expenses and restructuring expense, as well as the litigation settlement gain, all of which are excluded from the computation of adjusted net income from continuing operations.

Segment Results

Huron Healthcare

Revenues

Huron Healthcare segment revenues increased $15.2 million, or 24.1%, to $78.7 million for the first quarter of 2013 from $63.5 million for the first quarter of 2012. Revenues from time-and-expense engagements, fixed-fee engagements, performance-based arrangements and software support and maintenance arrangements represented 1.2%, 70.5%, 23.4% and 4.9% of this segment’s revenues during the three months ended March 31, 2013, respectively, compared to 1.5%, 68.0%, 24.5% and 6.0%, respectively, for the comparable period in 2012.

Of the overall $15.2 million increase in revenues, $15.0 million was attributable to our full-time billable consultants. The increase in demand for our services reflected the increased pressures our clients face as the result of evolving business models, rising costs, and declining reimbursements from government and commercial payers. The increase in full-time billable consultant revenues reflected increases in the average number of full-time billable consultants, average billing rate and consultant utilization rate. Performance-based fee revenues were $18.4 million during the first quarter of 2013 compared to $15.5 million during the first quarter of 2012. Performance-based fee engagements may cause significant variations in quarterly revenues, operating results and average billing rates due to the timing of achievement of the performance-based criteria.

Operating Income

Huron Healthcare segment operating income increased $15.4 million, or 96.7%, to $31.2 million in the three months ended March 31, 2013 from $15.8 million in the three months ended March 31, 2012. The Huron Healthcare segment operating margin, defined as segment operating income expressed as a percentage of segment revenues, increased to 39.6% for the first quarter of 2013 from 25.0% in the same period last year. The increase in this segment’s operating margin was primarily attributable to a decrease in salaries, bonus and related expenses for our revenue-generating professionals as a percentage of revenues, and decreases in technology expense, intangible asset amortization expense, practice administration and meeting expenses and contractor expense.

Huron Legal

Revenues

Huron Legal segment revenues decreased $0.5 million, or 1.1%, to $40.9 million for the first quarter of 2013 from $41.4 million for the first quarter of 2012. Revenues from time-and-expense engagements, fixed-fee engagements, and support and maintenance arrangements represented 94.4%, 5.4%, and 0.2%, respectively, of this segment’s revenues during the three months ended March 31, 2013. Revenues from time-and-expense engagements and fixed-fee engagements represented 95.6% and 4.4%, respectively, of this segment’s revenues for the comparable period in 2012.

27

Of the overall $0.5 million decrease in revenues, $1.5 million was attributable to a decrease in revenues generated by our full-time billable consultants, partially offset by a $1.0 million increase in revenue generated by our full-time equivalents. The decrease in revenues reflected a decrease in demand for our advisory services, partially offset by a slight increase in demand for our document review and electronic data discovery services. The decrease in full-time billable consultant revenue reflected a lower consultant utilization rate and average billing rate, partially offset by an increase in the average number of full-time billable consultants. The increase in revenue attributable to our full-time equivalents was driven by an increase in the average number of full-time equivalents, partially offset by a decrease in the average revenue per full-time equivalent.

Operating Income

Huron Legal segment operating income decreased by $6.6 million, or 69.1%, to $2.9 million in the three months ended March 31, 2013 from $9.5 million in the three months ended March 31, 2012. Segment operating margin decreased to 7.2% for the first quarter of 2013 from 23.0% in the same period last year. The decrease in this segment’s operating margin was primarily attributable to increases in salaries, bonuses and related expenses for both our revenue-generating professionals and support personnel, technology expense, practice administration and meetings expenses, and promotion and sponsorship expenses, partially offset by a decrease in contractor expense as a percentage of revenues.

Huron Education and Life Sciences

Revenues

Huron Education and Life Sciences segment revenues increased $8.0 million, or 29.1%, to $35.7 million for the first quarter of 2013 from $27.7 million for the first quarter of 2012. Revenues from time-and-expense engagements, fixed-fee engagements and software support and maintenance arrangements represented 76.7%, 19.4% and 3.9% of this segment’s revenues during the three months ended March 31, 2013, respectively, compared to 72.1%, 23.5% and 4.4%, respectively, for the comparable period in 2012.

Of the overall $8.0 million increase in revenues, $6.3 million was attributable to our full-time billable consultants and $1.7 million was related to our full-time equivalents. The overall increase in demand for our services in the Huron Education and Life Sciences segment reflected the increased competitive pressures faced by our clients as the result of increased regulation, rising costs, and declining funding. The increase in revenues from our full-time billable consultants reflected an increase in the average number of full-time billable consultants, partially offset by decreases in average billing rate and consultant utilization rate. The increase in revenue attributable to our full-time equivalents was driven by an increase in the average number of full-time equivalents and the average revenue per full-time equivalent.

Operating Income

Huron Education and Life Sciences segment operating income increased $2.9 million, or 44.8%, to $9.4 million in the three months ended March 31, 2013 from $6.5 million in the three months ended March 31, 2012. The Huron Education and Life Sciences segment operating margin, defined as segment operating income expressed as a percentage of segment revenues, increased to 26.2% for the first quarter of 2013 from 23.3% in the same period last year. The increase in this segment’s operating margin was primarily attributable to decreases in salaries, bonus and related expenses for both our revenue-generating professionals and support personnel as a percentage of revenues, and decreases in promotion and sponsorship expenses and intangible asset amortization expense.

Huron Financial

Revenues

Huron Financial segment revenues increased $2.8 million, or 46.7%, to $8.6 million for the first quarter of 2013 from $5.8 million for the first quarter of 2012. Revenues from time-and-expense engagements, fixed-fee engagements, and performance-based arrangements represented 77.4%, 16.8%, and 5.8%, respectively, of this segment’s revenues during the first quarter of 2013. Revenues from time-and-expense engagements and fixed-fee engagements represented 72.4% and 27.6%, respectively, for the comparable period in 2012.

Of the overall $2.8 million increase in revenues, $2.9 million was attributable to an increase in revenues from our full-time billable consultants, partially offset by a $0.1 million decrease in revenue generated by our full-time equivalents. The overall increase in revenues is attributable to an increase in demand for our Restructuring and Turnaround practice services.

28

The increase reflected higher consultant utilization rate and average billing rate, partially offset by a decrease in the average number of full-time billable consultants.

Operating Income

Huron Financial segment operating income increased by $3.2 million to $3.4 million in the three months ended March 31, 2013 compared to $0.2 million in the three months ended March 31, 2012. Segment operating margin increased to 39.4% for the first quarter of 2013 from 4.0% in the same period last year. The increase in this segment’s operating margin was primarily attributable to a decrease in salaries, bonus and related expenses for our revenue-generating professionals.

LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents decreased $19.4 million, from $25.2 million at December 31, 2012 to $5.7 million at March 31, 2013. Our primary sources of liquidity are cash flows from operations and debt capacity available under our credit facility.

	Three Months Ended March 31,
Cash Flows (in thousands):	2013			2012
Net cash used in operating activities	$	(24,826	)	$	(12,551	)
Net cash used in investing activities		(4,775	)		(36,926	)
Net cash provided by financing activities		10,265			47,930

Cash used in operating activities totaled $24.8 million for the three months ended March 31, 2013 and $12.6 million for the same period last year. Our operating assets and liabilities consist primarily of receivables from billed and unbilled services, accounts payable and accrued expenses, and accrued payroll and related benefits. The volume of services rendered and the related billings and timing of collections on those billings, as well as payments of our accounts payable and salaries, bonuses and benefits to employees affect these account balances. The increase in cash used in operations in the first three months of 2013 compared to the first three months of 2012 was primarily attributable to decreased collections of receivables and unbilled services from clients and increased tax payments, partially offset by higher net income and lower bonus payments during the first quarter of 2013 when compared with the first quarter of 2012.

Cash used in investing activities was $4.8 million for the three months ended March 31, 2013 and $36.9 million for the same period last year. The use of cash during the first three months of 2012 included payments for businesses acquired in prior periods totaling $31.3 million. These payments for acquired businesses were primarily comprised of additional purchase consideration earned by the selling shareholders of businesses that we acquired based on the achievement of financial performance targets as specified in the related purchase agreements. As of December 31, 2012, we had no further obligations under these arrangements. The use of cash in the first three months of 2013 and 2012 included purchases of property and equipment of $3.6 million and $5.3 million, respectively. We estimate that the cash utilized for capital expenditures in 2013 will be approximately $25.0 million, primarily consisting of information technology related equipment and leasehold improvements to support continued growth of our document review and processing services, as well as information technology related equipment to support our corporate infrastructure.

During 2011, the Company and certain of the Company’s subsidiaries as guarantors entered into an Amended and Restated Credit Agreement with various financial institutions, as amended by the first amendment to the credit agreement dated as of August 31, 2012 (collectively, the “2011 Credit Agreement”). The 2011 Credit Agreement replaced the previous Credit Agreement, dated as of June 7, 2006, and all subsequent amendments thereto, by and among the Company and the lenders therein.

The 2011 Credit Agreement consists of a senior secured credit facility in an aggregate principal amount of $450.0 million comprised of a five-year revolving credit facility (“Revolver”) under which the Company may borrow from time to time up to $247.5 million and a $202.5 million five-year term loan facility (“Term Loan”) that was funded in a single advance on the closing date of the first amendment. The 2011 Credit Agreement provides for the option to increase the revolving credit facility in an aggregate amount of up to $50 million subject to certain requirements as defined in the 2011 Credit Agreement. The proceeds of the senior secured credit facility were used to refinance existing indebtedness and will continue to be used for working capital, capital expenditures, and other corporate purposes.

The obligations under the 2011 Credit Agreement are secured pursuant to a Security Agreement with Bank of America as Administrative Agent. The Security Agreement grants Bank of America, N.A. for the ratable benefit of the lenders under the 2011 Credit Agreement, a first-priority lien, subject to permitted liens, on substantially all of the personal property assets of the Company and the subsidiary guarantors. The Revolver and Term Loan are also secured by a pledge of 100% of the voting stock or other equity interests in our domestic subsidiaries and 65% of the voting stock or other equity interests in our foreign subsidiaries.

29

Fees and interest on borrowings vary based on our total debt to earnings before interest, taxes, depreciation and amortization (“EBITDA”) ratio as set forth in the 2011 Credit Agreement. Interest is based on a spread over the London Interbank Offered Rate (“LIBOR”) or a spread over the base rate, as selected by the Company. The base rate is the greater of (a) the Federal Funds Rate plus 0.5%, (b) the Prime Rate and (c) except during a Eurodollar Unavailability Period, the Eurodollar Rate plus 1.0%.

The Term Loan, as amended, is subject to scheduled quarterly amortization payments equal to 4.9% of the original principal balance in 2012, which was paid as of December 31, 2012, 11.7% in 2013, 12.4% in 2014, 14.2% in 2015, 14.8% in 2016 and 42.0% in 2017, as set forth in the 2011 Credit Agreement. The maturity date for the Term Loan is August 31, 2017, at which time the outstanding principal balance and all accrued interest will be due and payable in full. All outstanding borrowings under the Revolver, as amended, will be due upon expiration of the 2011 Credit Agreement on August 31, 2017.

Under the 2011 Credit Agreement, dividends are restricted to an amount up to $50 million plus 50% of cumulative consolidated net income from the closing date of the 2011 Credit Agreement plus 50% of the net cash proceeds from equity issuances. In addition, certain acquisitions and similar transactions need to be approved by the lenders.

The 2011 Credit Agreement contains quarterly financial covenants that require us to maintain a minimum fixed charge coverage ratio of 2.25 to 1.00 and a maximum leverage ratio that varies throughout the term and was 3.25 to 1.00 as of March 31, 2013, as those ratios are defined therein, as well as a minimum net worth greater than $150 million. At March 31, 2013, we were in compliance with these financial covenants with a fixed charge coverage ratio of 3.81 to 1.00, a leverage ratio of 1.54 to 1.00, and net worth greater than $150 million. At December 31, 2012, we were also in compliance with our financial covenants.

The borrowing capacity under the 2011 Credit Agreement is reduced by any outstanding letters of credit and payments under the Term Loan. At March 31, 2013, outstanding letters of credit totaled $5.1 million and are primarily used as security deposits for our office facilities. As of March 31, 2013, the unused borrowing capacity under the 2011 Credit Agreement was $227.4 million. Borrowings outstanding under this credit facility at March 31, 2013 totaled $202.5 million. These borrowings carried a weighted average interest rate of 2.6%, including the effect of the interest rate swaps described in Note 9 “Derivative Instruments and Hedging Activity.” During the first three months of 2013, the average daily outstanding balance under our credit facility was $195.4 million. Borrowings outstanding at December 31, 2012 were $192.5 million and carried a weighted average interest rate of 2.5%. Effective March 31, 2013, we have classified as current liabilities, the scheduled quarterly principal payments due under the Term Loan within twelve months of the balance sheet date, as we intend to make these payments with cash from operations rather than from availability under the Revolver.

See “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2012 for a discussion of certain risks and uncertainties related to the 2011 Credit Agreement.

Future Needs

Our primary financing need has been to fund our growth. Our growth strategy is to expand our service offerings, which may require investments in new hires, acquisitions of complementary businesses, possible expansion into other geographic areas, and related capital expenditures. We also have cash needs to service our credit facility and repay our Term Loan. We believe our internally generated liquidity, together with the borrowing capacity available under our revolving credit facility and access to external capital resources will be adequate to fund our long-term growth and capital needs arising from cash commitments and debt service obligations. Our ability to secure short-term and long-term financing in the future will depend on several factors, including our future profitability, the quality of our accounts receivable and unbilled services, our relative levels of debt and equity, and the overall condition of the credit markets.

30

CONTRACTUAL OBLIGATIONS

For a summary of our commitments to make future payments under contractual obligations, see “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Contractual Obligations” in our Annual Report on Form 10-K for the year ended December 31, 2012. There have been no significant changes in our contractual obligations since December 31, 2012 except as described below:

• During the first three months of 2013, our long-term borrowings increased from $192.5 million as of December 31, 2012 to $202.5 million as of March 31, 2013.

OFF-BALANCE SHEET ARRANGEMENTS

We have not entered into any off-balance sheet arrangements.

NEW ACCOUNTING PRONOUNCEMENTS

In February 2013, the FASB issued ASU No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, which amends current accounting guidance on comprehensive income. The guidance requires an entity to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income if the amount is reclassified to net income in its entirety in the same reporting period. For other amounts not required to be reclassified in their entirety to net income in the same reporting period, a cross reference to other disclosures that provide additional detail about the reclassification amounts is required. The Company adopted this guidance effective January 1, 2013. The guidance required a change in disclosure only and did not have any effect on the Company’s consolidated financial statements.

In March 2013, the FASB issued ASU No. 2013-05, Parent’s Accounting for the Cumulative Translation Adjustment Upon Derecognition of Certain Subsidiaries or Groups of Assets Within a Foreign Entity or of an Investment in a Foreign Entity, which amends current accounting guidance on foreign currency matters. This guidance requires that the entire amount of a cumulative translation adjustment related to an entity’s investment in a foreign entity should be released when there has been a: (i) sale of a subsidiary or group of net assets within a foreign entity and the sale represents the substantially complete liquidation of the investment in the foreign entity, (ii) loss of a controlling financial interest in an investment in a foreign entity, and (iii) step acquisition for a foreign entity. This guidance will be effective for the Company beginning in the first quarter of 2014. We do not expect the adoption to have a material impact on our consolidated financial statements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to market risks primarily from changes in interest rates and changes in the market value of our investments.

Our exposure to changes in interest rates is limited to borrowings under our bank credit facility, which has variable interest rates tied to the LIBOR, Federal Funds Rate, Prime Rate, or Eurodollar Rate. At March 31, 2013, we had borrowings outstanding totaling $202.5 million that carried a weighted average interest rate of 2.6% including the effect of the interest rate swaps described below. A hypothetical 100 basis point change in this interest rate would have a $1.2 million effect on our pretax income including the effect of the interest rate swaps described below.

On December 8, 2011, we entered into a forward amortizing interest rate swap agreement effective on February 29, 2012 and ending on April 14, 2016. We entered into this derivative instrument to hedge against the interest rate risks of our variable-rate borrowings described above. The swap had an initial notional amount of $56.6 million and amortizes throughout the term. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one-month LIBOR and we pay to the counterparty a fixed rate of 0.9875%.

On May 30, 2012, we entered into an additional forward amortizing interest rate swap agreement effective on May 31, 2012 and ending on April 14, 2016. We entered into this derivative instrument to further hedge against the interest rate risks of our variable-rate borrowings described above. The swap had an initial notional amount of $37.0 million and amortizes throughout the term. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one-month LIBOR and we pay to the counterparty a fixed rate of 0.70%.

Including the impact of the above swap agreements, the effective interest rate on $82.5 million of our debt, which equals the notional amount of the swap agreements at March 31, 2013, was 2.9%.

We have not entered into any other interest rate swaps, caps or collars or other hedging instruments as of March 31, 2013.

31

On April 4, 2013, we entered into a one-year forward amortizing interest rate swap agreement effective on March 31, 2014 and ending on August 31, 2017. We entered into this derivative instrument to further hedge against the interest rate risks of our variable-rate borrowings described above. The swap has an initial notional amount of $60.0 million and amortizes throughout the term. Under the terms of the interest rate swap agreement, we will receive from the counterparty interest on the notional amount based on one-month LIBOR and we will pay to the counterparty a fixed rate of 0.985%.

From time to time, we invest excess cash in marketable securities. These investments principally consist of overnight sweep accounts. Due to the short maturity of our investments, we have concluded that we do not have material market risk exposure.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of March 31, 2013. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of March 31, 2013, our disclosure controls and procedures were effective in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by us in the reports we file or submit under the Exchange Act and such information is accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosure.

Changes in Control over Financial Reporting

There has been no change in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the “Exchange Act”) that occurred during the three months ended March 31, 2013 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II—OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Qui Tam Action

On December 9, 2009, plaintiff, Associates Against Outlier Fraud, filed a first amended qui tam complaint against Huron Consulting Group Inc. and others under the federal and New York state False Claims Act (“FCA”) in the United States District Court for the Southern District of New York. The federal and state FCA authorize private individuals (known as “relators”) to sue on behalf of the government (known as “qui tam” actions) alleging that false or fraudulent claims were knowingly submitted to the government. Once a qui tam action is filed, the government may elect to intervene in the action. If the government declines to intervene, the relator may proceed with the action. Under the federal and state FCA, the government may recover treble damages and civil penalties (civil penalties of up to $11,000 per violation under the federal FCA and $12,000 per violation under the state FCA). On January 6, 2010, the United States declined to intervene in the lawsuit. After the Court granted Huron’s motion to dismiss without prejudice, on September 29, 2010, the relator filed a second amended complaint alleging that Huron and others caused St. Vincent Catholic Medical Center to receive more than $30 million in inflated outlier payments under the Medicare and Medicaid programs in violation of the federal and state FCA and seeking to recover an unspecified amount of civil penalties. On March 8, 2013, the Court granted Huron’s motion for summary judgment and dismissed relator’s second amended complaint in its entirety with prejudice. As a result, we reversed the charge of $1.2 million relating to settlement discussions which we recorded in the second quarter of 2012, in accordance with FASB ASC Topic 450, “Contingencies.” The relator filed an appeal on April 2, 2013. On April 8, 2013, Huron filed an appeal of an earlier denial of a motion to dismiss filed by Huron which argued that relator’s action was barred because, under the FCA jurisdictional bar, the action was based on publicly disclosed information and relator cannot qualify as an original source. We continue to believe that the claims are without merit and intend to vigorously defend ourselves in this matter.

From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. As of the date of this Quarterly Report on Form 10-Q, we are not a party to or threatened with any other litigation or legal proceeding that, in the current opinion of management, could have a material adverse effect on our financial position or results of operations. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results.

32

ITEM 1A. RISK FACTORS

See “Risk Factors” in our 2012 Annual Report on Form 10-K for a complete description of the material risks we face.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Our 2012 Omnibus Incentive Plan and our 2004 Omnibus Stock Plan, which was replaced by the 2012 Omnibus Incentive Plan, permit the netting of common stock upon vesting of restricted stock awards to satisfy individual tax withholding requirements. During the quarter ended March 31, 2013, we re-acquired 16,283 shares of common stock with a weighted average fair market value of $34.69 as a result of such tax withholdings as presented in the table below. We do not have any publicly announced share repurchase plans or programs.

Period	Total Number of Shares Withheld to Satisfy Employee Tax Withholding Requirements		Weighted Average Fair Market Value Per Share Withheld		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs		Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
January 2013		11,319	$	33.29		N/A		N/A
February 2013		1,214	$	35.45		N/A		N/A
March 2013		3,750	$	38.67		N/A		N/A
Total		16,283	$	34.69		N/A		N/A

N/A – Not applicable.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

33

ITEM 6. EXHIBITS

(a) The following exhibits are filed as part of this Quarterly Report on Form 10-Q.

		Filed here- with		Incorporated by Reference
Exhibit Number	Exhibit Description			Form	Period Ending	Exhibit	Filing Date
31.1	Certification of the Chief Executive Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.		X
31.2	Certification of the Chief Financial Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.		X
32.1	Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.		X
32.2	Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.		X
101.INS	XBRL Instance Document		X
101.SCH	XBRL Taxonomy Extension Schema Document		X
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document		X
101.LAB	XBRL Taxonomy Extension Label Linkbase Document		X
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document		X
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document		X

34

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Huron Consulting Group Inc.
	(Registrant)
Date: April 26, 2013	/s/ C. Mark Hussey
	C. Mark Hussey
	Executive Vice President, Chief Financial Officer and Treasurer

35

EX-31.1

EXHIBIT 31.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER,

PURSUANT TO RULE 13a-14(a)/15d-14(a), AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, James H. Roth, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Huron Consulting Group Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 26, 2013	By:	/s/ James H. Roth
		James H. Roth
		President and Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER,

PURSUANT TO RULE 13a-14(a)/15d-14(a), AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, C. Mark Hussey, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Huron Consulting Group Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 26, 2013	By:	/s/ C. Mark Hussey
		C. Mark Hussey
		Executive Vice President, Chief Financial Officer and Treasurer

EX-32.1

EXHIBIT 32.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER,

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Huron Consulting Group Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2013 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, James H. Roth, President and Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.

Date: April 26, 2013	By:	/s/ James H. Roth
		James H. Roth
		President and Chief Executive Officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

The foregoing certification is being furnished to the Securities and Exchange Commission as an exhibit to the Form 10-Q and shall not be considered filed as part of the Form 10-Q.

EX-32.2

EXHIBIT 32.2

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER,

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Huron Consulting Group Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2013 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, C. Mark Hussey, Executive Vice President, Chief Financial Officer and Treasurer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.

Date: April 26, 2013	By:	/s/ C. Mark Hussey
		C. Mark Hussey
		Executive Vice President, Chief Financial Officer and Treasurer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

The foregoing certification is being furnished to the Securities and Exchange Commission as an exhibit to the Form 10-Q and shall not be considered filed as part of the Form 10-Q.

XML

Derivative Instruments and Hedging Activity (Details Textual) (USD $) In Millions, unless otherwise specified	1 Months Ended				3 Months Ended
	Apr. 30, 2013	May 31, 2012	Dec. 31, 2011	Mar. 31, 2009	Mar. 31, 2013	Apr. 04, 2013	May 30, 2012	Dec. 08, 2011	Mar. 20, 2009
Derivative Instruments and Hedging Activity (Textual) [Abstract]
Interest rate swap agreement for a notional amount						$ 60.0	$ 37.0	$ 56.6	$ 100.0
Interest rate swap agreement, effective date		May 31, 2012	Feb. 29, 2012	Mar. 31, 2009	Mar. 31, 2014
Interest rate swap agreement, end date		Apr. 14, 2016	Apr. 14, 2016	Feb. 23, 2012	Aug. 31, 2017
Variable-rate borrowings outstanding									100.0
Fixed-rate borrowings									100.0
Duration of LIBOR	1 month	1 month	1 month	1 month
Percentage of fixed rate						0.985%	0.70%	0.9875%	1.715%
Anticipated net losses, net of tax, currently recorded in OCI reclassified into earnings					$ 0.3

XML

Segment Information (Details Textual)	3 Months Ended	12 Months Ended
	Mar. 31, 2013 Client Segment	Dec. 31, 2012 Client
Segment Information (Textual) [Abstract]
Number of operating segments	5
Percentage of total receivables and unbilled services balances for which no single client reached	10.00%	10.00%
Number of single client accounted for greater than 10% of combined receivables and unbilled services balances	0	0
Customer revenues as a percentage of consolidated revenue, for which no single client reached	10.00%	10.00%
Number of single client generated greater than 10% of consolidated revenues	0	0

XML

Segment Information (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Components of Segment Information
Revenues	$ 164,036	$ 138,637
Operating income (loss)	21,343	3,637
Reimbursable expenses	15,336	13,796
Total revenues and reimbursable expenses	179,372	152,433
Statement of Earnings reconciliation:
Segment operating income	46,658	31,241
Charges not allocated at the segment level:
Other selling, general and administrative expenses	20,536	22,951
Depreciation and amortization expense	4,779	4,653
Other expense, net	1,850	1,533
Income from continuing operations before income tax expense	19,493	2,104
Huron Healthcare [Member]
Components of Segment Information
Revenues	78,745	63,465
Operating income (loss)	31,161	15,838
Segment operating income (loss) as a percent of segment revenues	39.60%	25.00%
Huron Legal [Member]
Components of Segment Information
Revenues	40,944	41,383
Operating income (loss)	2,938	9,511
Segment operating income (loss) as a percent of segment revenues	7.20%	23.00%
Huron Education and Life Sciences [Member]
Components of Segment Information
Revenues	35,726	27,676
Operating income (loss)	9,352	6,458
Segment operating income (loss) as a percent of segment revenues	26.20%	23.30%
Huron Financial [Member]
Components of Segment Information
Revenues	8,582	5,849
Operating income (loss)	3,379	233
Segment operating income (loss) as a percent of segment revenues	39.40%	4.00%
All Other [Member]
Components of Segment Information
Revenues	39	264
Operating income (loss)	$ (172)	$ (799)
Segment operating income (loss) as a percent of segment revenues

XML

Goodwill and Intangible Assets (Details Textual) (USD $)	3 Months Ended
	Mar. 31, 2013 Segment	Mar. 31, 2012	Dec. 31, 2012
Goodwill and Intangible Assets (Additional Textual) [Abstract]
Number of operating segments	5
Reassigned amount of goodwill			$ 662,505,000
Goodwill and intangible assets (Textual) [Abstract]
Number of reportable segments	5
Future cash flow forecast period	6 years
Long-term assumed annual revenue growth rate	3.50%
Weighted average cost of capital (WACC) discount rate	13.00%
Intangible assets amortization expense	1,500,000	1,600,000
Estimated annual intangible assets amortization expense 2013	5,800,000
Estimated annual intangible assets amortization expense 2014	4,500,000
Estimated annual intangible assets amortization expense 2015	3,100,000
Estimated annual intangible assets amortization expense 2016	1,800,000
Estimated annual intangible assets amortization expense 2017	1,200,000
Estimated annual intangible assets amortization expense 2018	700,000
Huron Healthcare [Member]
Goodwill and Intangible Assets (Additional Textual) [Abstract]
Reassigned amount of goodwill	355,880,000		355,880,000
Huron Education and Life Sciences [Member]
Goodwill and Intangible Assets (Additional Textual) [Abstract]
Reassigned amount of goodwill	94,601,000		94,601,000
Health and Education Consulting [Member]
Goodwill and Intangible Assets (Additional Textual) [Abstract]
Number of operating segments	2
Reassigned amount of goodwill			450,481,000
Health and Education Consulting [Member] | Huron Healthcare [Member]
Goodwill and Intangible Assets (Additional Textual) [Abstract]
Reassigned amount of goodwill			355,880,000
Health and Education Consulting [Member] | Huron Education and Life Sciences [Member]
Goodwill and Intangible Assets (Additional Textual) [Abstract]
Reassigned amount of goodwill			$ 94,601,000

XML

Derivative Instruments and Hedging Activity (Tables)

3 Months Ended

Mar. 31, 2013

Derivative Instruments and Hedging Activity [Abstract]

Fair Value interest rate swaps designated as cash flow hedging instruments

	Fair Value (Derivative Liability)
Balance Sheet Location	March 31, 2013		December 31, 2012
Accrued expenses	$	455	$	493
Deferred compensation and other liabilities	$	365	$	439

XML

Other Comprehensive (Loss) Income (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Other comprehensive (loss) income:
Foreign currency translation adjustment, before taxes	$ (1,048)	$ 353
Foreign currency translation adjustment, tax (expense) benefit	51	(114)
Foreign currency translation adjustment, net of taxes	(997)	239
Unrealized gain on cash flow hedges:
Change in fair value, before taxes	(25)	(173)
Change in fair value, tax (expense) benefit	11	70
Change in fair value, net of taxes	(14)	(103)
Reclassification adjustments into earnings, before taxes	137	254
Reclassification adjustments into earnings, tax (expense) benefit	(55)	(102)
Reclassification adjustments into earnings, net of taxes	82	152
Net unrealized gain, before taxes	112	81
Net unrealized gain, tax (expenses) benefit	(44)	(32)
Net unrealized gain, net of taxes	68	49
Other comprehensive (loss) income, before taxes	(936)	434
Other comprehensive (loss) income, tax (expense) benefit	7	(146)
Other comprehensive (loss) income	$ (929)	$ 288

XML

Restructuring Charges (Details Textual) (USD $)	3 Months Ended		3 Months Ended
	Mar. 31, 2012	Mar. 31, 2013	Dec. 31, 2012 New York [Member] Office
Restructuring Charges (Additional Textual) [Abstract]
Number of offices relocated			1
Restructuring Charges (Textual) [Abstract]
Restructuring charge liability		$ 1,000,000
Pre-tax restructuring expenses	$ 830,000

XML

Segment Information (Details 1) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2012
Segment assets:
Total assets	$ 776,075	$ 787,900
Huron Healthcare [Member]
Segment assets:
Total assets	78,050	60,288
Huron Legal [Member]
Segment assets:
Total assets	44,973	51,594
Huron Education and Life Sciences [Member]
Segment assets:
Total assets	31,985	31,129
Huron Financial [Member]
Segment assets:
Total assets	5,394	1,462
All Other [Member]
Segment assets:
Total assets	41	50
Unallocated assets [Member]
Segment assets:
Total assets	$ 615,632	$ 643,377

XML

New Accounting Pronouncements

3 Months Ended

Mar. 31, 2013

New Accounting Pronouncements [Abstract]

New Accounting Pronouncements

3.       New Accounting Pronouncements

In February 2013, the FASB issued ASU No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, which amends current accounting guidance on comprehensive income. The guidance requires an entity to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income if the amount is reclassified to net income in its entirety in the same reporting period. For other amounts not required to be reclassified in their entirety to net income in the same reporting period, a cross reference to other disclosures that provide additional detail about the reclassification amounts is required. The Company adopted this guidance effective January 1, 2013. The guidance required a change in disclosure only and did not have any effect on the Company’s consolidated financial statements.

In March 2013, the FASB issued ASU No. 2013-05, Parent’s Accounting for the Cumulative Translation Adjustment Upon Derecognition of Certain Subsidiaries or Groups of Assets Within a Foreign Entity or of an Investment in a Foreign Entity, which amends current accounting guidance on foreign currency matters. This guidance requires that the entire amount of a cumulative translation adjustment related to an entity’s investment in a foreign entity should be released when there has been a: (i) sale of a subsidiary or group of net assets within a foreign entity and the sale represents the substantially complete liquidation of the investment in the foreign entity, (ii) loss of a controlling financial interest in an investment in a foreign entity, and (iii) step acquisition for a foreign entity. This guidance will be effective for the Company beginning in the first quarter of 2014. We do not expect the adoption to have a material impact on our consolidated financial statements.

XML

Other Comprehensive (Loss) Income (Details 1) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Components of accumulated other comprehensive loss, net of tax
Foreign Currency Translation Adjustments, Beginning balance	$ (805)
Foreign Currency Translation Adjustments, Current period change	(997)	239
Foreign Currency Translation Adjustments, Ending balance	(1,802)
Net Unrealized Gains/(Losses) on Derivatives, Beginning balance	(554)
Net Unrealized Gains/(Losses) on Derivatives, Current period change	68	49
Net Unrealized Gains/(Losses) on Derivatives, Ending balance	(486)
Accumulated Other Comprehensive Loss, Beginning balance	(1,359)
Accumulated Other Comprehensive Loss, Current period change	(929)	288
Accumulated Other Comprehensive Loss, Ending balance	$ (2,288)

XML

Discontinued Operations (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Summarized operating results of discontinued operations
Revenues	$ 33	$ 390
(Loss) income from discontinued operations before income tax expense	(53)	424
Net (loss) income from discontinued operations	$ (32)	$ 269

XML

Segment Information (Tables)

3 Months Ended

Mar. 31, 2013

Segment Information [Abstract]

Components of segment information

	Three Months Ended March 31,
	2013			2012
Huron Healthcare:
Revenues	$	78,745		$	63,465
Operating income	$	31,161		$	15,838
Segment operating income as a percent of segment revenues		39.6	%		25.0	%
Huron Legal:
Revenues	$	40,944		$	41,383
Operating income	$	2,938		$	9,511
Segment operating income as a percent of segment revenues		7.2	%		23.0	%
Huron Education and Life Sciences:
Revenues	$	35,726		$	27,676
Operating income	$	9,352		$	6,458
Segment operating income as a percent of segment revenues		26.2	%		23.3	%
Huron Financial:
Revenues	$	8,582		$	5,849
Operating income	$	3,379		$	233
Segment operating income as a percent of segment revenues		39.4	%		4.0	%
All Other:
Revenues	$	39		$	264
Operating loss	$	(172	)	$	(799	)
Segment operating loss as a percent of segment revenues		N/M			N/M
Total Company:
Revenues	$	164,036		$	138,637
Reimbursable expenses		15,336			13,796
Total revenues and reimbursable expenses	$	179,372		$	152,433
Statements of Earnings reconciliation:
Segment operating income	$	46,658		$	31,241
Charges not allocated at the segment level:
Other selling, general and administrative expenses		20,536			22,951
Depreciation and amortization expense		4,779			4,653
Other expense, net		1,850			1,533
Income from continuing operations before income tax expense	$	19,493		$	2,104

N/M - Not meaningful

Segment assets

	March 31, 2013		December 31, 2012
Segment Assets:
Huron Healthcare	$	78,050	$	60,288
Huron Legal		44,973		51,594
Huron Education and Life Sciences		31,985		31,129
Huron Financial		5,394		1,462
All Other		41		50
Unallocated assets (1)		615,632		643,377
Total assets	$	776,075	$	787,900

(1) Goodwill and intangible assets are included in unallocated assets, as management does not evaluate these items at the segment level when assessing segment performance or allocating resources.

XML

Income Taxes (Details Textual) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Income Taxes (Textual) [Abstract]
Effective tax rates	41.70%	72.10%
Impact of foreign losses	$ 0

XML

Discontinued Operations (Details Textual) (Accounting Advisory [Member], USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011
Accounting Advisory [Member]
Discontinued Operations (Textual) [Abstract]
Loss on sale of Accounting Advisory	$ 1.9

XML

Goodwill and Intangible Assets (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Dec. 31, 2012
Changes in the carrying amount of goodwill
Goodwill		$ 662,505
Accumulated impairment		(142,983)
Goodwill, net as of December 31, 2012	519,522
Foreign currency translation	(606)
Goodwill, net as of March 31, 2013	518,916
Health and Education Consulting [Member]
Changes in the carrying amount of goodwill
Goodwill		450,481
Legal Consulting [Member]
Changes in the carrying amount of goodwill
Goodwill		52,947
Financial Consulting [Member]
Changes in the carrying amount of goodwill
Goodwill		159,077
Huron Healthcare [Member]
Changes in the carrying amount of goodwill
Goodwill	355,880	355,880
Goodwill, net as of December 31, 2012		355,880
Goodwill, net as of March 31, 2013	355,880	355,880
Huron Healthcare [Member] | Health and Education Consulting [Member]
Changes in the carrying amount of goodwill
Goodwill		355,880
Huron Legal [Member]
Changes in the carrying amount of goodwill
Goodwill		52,947
Goodwill, net as of December 31, 2012	52,947
Foreign currency translation	(606)
Goodwill, net as of March 31, 2013	52,341
Huron Legal [Member] | Legal Consulting [Member]
Changes in the carrying amount of goodwill
Goodwill		52,947
Huron Education and Life Sciences [Member]
Changes in the carrying amount of goodwill
Goodwill	94,601	94,601
Goodwill, net as of December 31, 2012		94,601
Goodwill, net as of March 31, 2013	94,601	94,601
Huron Education and Life Sciences [Member] | Health and Education Consulting [Member]
Changes in the carrying amount of goodwill
Goodwill		94,601
Huron Financial [Member]
Changes in the carrying amount of goodwill
Goodwill		159,077
Accumulated impairment		(142,983)
Goodwill, net as of December 31, 2012		16,094
Goodwill, net as of March 31, 2013	16,094	16,094
Huron Financial [Member] | Financial Consulting [Member]
Changes in the carrying amount of goodwill
Goodwill		$ 159,077

XML

Basis of Presentation

3 Months Ended

Mar. 31, 2013

Description of Business and Basis of Presentation [Abstract]

Basis of Presentation

2.       Basis of Presentation

The accompanying unaudited Consolidated Financial Statements reflect the financial position, results of operations and cash flows as of and for the three months ended March 31, 2013 and 2012. These financial statements have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10-Q. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements. In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair presentation of our financial position, results of operations and cash flows for the interim periods presented in conformity with GAAP. These financial statements should be read in conjunction with the Consolidated Financial Statements and notes thereto for the year ended December 31, 2012 included in our Annual Report on Form 10-K.

Certain amounts reported in the previous year have been reclassified to conform to the 2013 presentation. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.

XML

Goodwill and Intangible Assets (Details 1) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Dec. 31, 2012
Intangible assets
Gross Carrying Amount	$ 33,959	$ 34,063
Accumulated Amortization	16,622	15,184
Customer relationships [Member]
Intangible assets
Gross Carrying Amount	24,634	24,738
Accumulated Amortization	11,219	10,268
Non-competition agreements [Member]
Intangible assets
Gross Carrying Amount	4,684	4,684
Accumulated Amortization	3,295	3,067
Trade names [Member]
Intangible assets
Gross Carrying Amount	150	150
Accumulated Amortization	20	8
Technology and software [Member]
Intangible assets
Useful Life in Years	5 years
Gross Carrying Amount	4,041	4,041
Accumulated Amortization	1,953	1,751
Document reviewer database [Member]
Intangible assets
Useful Life in Years	3 years
Gross Carrying Amount	450	450
Accumulated Amortization	$ 135	$ 90
Minimum [Member] | Customer relationships [Member]
Intangible assets
Useful Life in Years	3 years
Minimum [Member] | Non-competition agreements [Member]
Intangible assets
Useful Life in Years	1 year
Minimum [Member] | Trade names [Member]
Intangible assets
Useful Life in Years	1 year
Maximum [Member] | Customer relationships [Member]
Intangible assets
Useful Life in Years	13 years
Maximum [Member] | Non-competition agreements [Member]
Intangible assets
Useful Life in Years	6 years
Maximum [Member] | Trade names [Member]
Intangible assets
Useful Life in Years	8 years

XML

Fair Value of Financial Instruments (Details) (Fair Value, Measurements, Recurring [Member], USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2012
Liabilities:
Liabilities, fair value	$ 11,362	$ 11,457
Deferred acquisition payments [Member]
Liabilities:
Liabilities, fair value	10,542	10,525
Promissory note [Member]
Asset:
Asset, fair value	2,974	2,907
Interest rate swaps [Member]
Liabilities:
Liabilities, fair value	820	932
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Liabilities:
Liabilities, fair value
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Deferred acquisition payments [Member]
Liabilities:
Liabilities, fair value
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Promissory note [Member]
Asset:
Asset, fair value
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Interest rate swaps [Member]
Liabilities:
Liabilities, fair value
Significant Other Observable Inputs (Level 2) [Member]
Liabilities:
Liabilities, fair value	820	932
Significant Other Observable Inputs (Level 2) [Member] | Interest rate swaps [Member]
Liabilities:
Liabilities, fair value	820	932
Significant Unobservable Inputs (Level 3) [Member]
Liabilities:
Liabilities, fair value	10,542	10,525
Significant Unobservable Inputs (Level 3) [Member] | Deferred acquisition payments [Member]
Liabilities:
Liabilities, fair value	10,542	10,525
Significant Unobservable Inputs (Level 3) [Member] | Promissory note [Member]
Asset:
Asset, fair value	$ 2,974	$ 2,907

XML

Consolidated Balance Sheets (Unaudited) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 5,749	$ 25,162
Receivables from clients, net	101,549	97,510
Unbilled services, net	59,123	47,232
Income tax receivable	1,003	192
Deferred income taxes, net	9,631	14,751
Prepaid expenses and other current assets	13,914	15,525
Total current assets	190,969	200,372
Property and equipment, net	33,269	33,805
Other non-current assets	15,584	15,322
Intangible assets, net	17,337	18,879
Goodwill	518,916	519,522
Total assets	776,075	787,900
Current liabilities:
Accounts payable	6,978	8,461
Accrued expenses	15,786	17,692
Accrued payroll and related benefits	32,869	61,672
Bank borrowings, current portion	25,000
Accrued consideration for business acquisitions, current portion	5,586	5,640
Income tax payable	165	7,872
Deferred revenues	15,345	15,388
Total current liabilities	101,729	116,725
Non-current liabilities:
Deferred compensation and other liabilities	7,140	6,973
Bank borrowings, net of current portion	177,500	192,500
Deferred lease incentives	6,874	6,936
Deferred income taxes	15,784	14,560
Accrued consideration for business acquisitions, net of current portion	4,956	4,885
Total non-current liabilities	212,254	225,854
Commitments and Contingencies
Stockholders' equity
Common stock; $0.01 par value; 500,000,000 shares authorized; 25,184,665 and 24,793,327 shares issued at March 31, 2013 and December 31, 2012, respectively	243	240
Treasury stock, at cost, 1,893,745 and 1,880,809 shares at March 31, 2013 and December 31, 2012, respectively	(84,137)	(83,715)
Additional paid-in capital	427,607	420,825
Retained earnings	120,667	109,330
Accumulated other comprehensive loss	(2,288)	(1,359)
Total stockholders' equity	462,092	445,321
Total liabilities and stockholders' equity	$ 776,075	$ 787,900

XML

Commitments, Contingencies and Guarantees (Details Textual) (USD $)	3 Months Ended
	Mar. 31, 2013	Jun. 30, 2012	Dec. 31, 2012
Commitments, Contingencies and Guarantees (Textual) [Abstract]
Maximum amount of civil penalties per violation under the federal False Claims Act	$ 11,000
Maximum amount of civil penalties per violation under the state False Claims Act	12,000
Alleged amount of outlier payments received	30,000,000
Settlement charges recorded during period	1,150,000	1,200,000
Guarantees in the form of letters of credit	$ 5,100,000		$ 5,100,000

XML

Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Cash flows from operating activities:
Net income	$ 11,337	$ 856
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	5,437	6,621
Share-based compensation	4,635	4,842
Allowances for doubtful accounts and unbilled services	6,953	2,246
Deferred income taxes	6,083	3,344
Changes in operating assets and liabilities, net of businesses acquired:
(Increase) decrease in receivables from clients	(4,742)	2,133
(Increase) decrease in unbilled services	(18,423)	4,456
(Increase) decrease in current income tax receivable / payable, net	(8,513)	2,379
(Increase) decrease in other assets	2,459	1,853
Increase (decrease) in accounts payable and accrued liabilities	(3,000)	3,492
Increase (decrease) in accrued payroll and related benefits	(27,018)	(36,795)
Increase (decrease) in deferred revenues	(34)	(7,978)
Net cash used in operating activities	(24,826)	(12,551)
Cash flows from investing activities:
Purchases of property and equipment, net	(3,576)	(5,267)
Net investment in life insurance policies	(507)	(361)
Purchases of businesses, net of cash acquired		(31,298)
Capitalization of internally developed software	(692)
Net cash used in investing activities	(4,775)	(36,926)
Cash flows from financing activities:
Proceeds from exercise of stock options	27	29
Shares redeemed for employee tax withholdings	(565)	(3,710)
Tax benefit from share-based compensation	803	1,116
Proceeds from borrowings under credit facility	22,000	93,000
Repayments on credit facility	(12,000)	(42,500)
Payments of capital lease obligations		(5)
Net cash provided by financing activities	10,265	47,930
Effect of exchange rate changes on cash	(77)	430
Net decrease in cash and cash equivalents	(19,413)	(1,117)
Cash and cash equivalents at beginning of the period	25,162	5,080
Cash and cash equivalents at end of the period	$ 5,749	$ 3,963

XML

Earnings Per Share (Details Textual)	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Earnings Per Share (Textual) [Abstract]
Weighted average common stock equivalents antidilutive	78,900	22,000

XML

Discontinued Operations (Tables)

3 Months Ended

Mar. 31, 2013

Discontinued Operations [Abstract]

Summarized operating results of discontinued operations

	Three Months Ended March  31,
	2013			2012
Revenues	$	33		$	390
(Loss) income from discontinued operations before income tax expense	$	(53	)	$	424
Net (loss) income from discontinued operations	$	(32	)	$	269

XML

Borrowings (Details Textual) (USD $) In Millions, unless otherwise specified	3 Months Ended	12 Months Ended
	Mar. 31, 2013	Dec. 31, 2012
Borrowings (Textual) [Abstract]
Aggregate principal amount	$ 450.0
Borrowings (Additional Textual) [Abstract]
Period of revolving credit facility	5 years
Period of term loan facility	5 years
Aggregate amount of option available to increase the revolving credit facility	50
Percentage of other equity interests in domestic subsidiaries	100.00%
Percentage of other equity interests in foreign subsidiaries	65.00%
Percentage of Federal Funds Rate	0.50%
Percentage of Eurodollar Rate	1.00%
Percentage of original principal balance in year one		4.90%
Percentage of original principal balance in year two		11.70%
Percentage of original principal balance in year three		12.40%
Percentage of original principal balance in year four		14.20%
Percentage of original principal balance in year five		14.80%
Percentage of original principal balance in year six		42.00%
Maturity date	Aug. 31, 2017
Credit Agreement, dividends restriction amount	50
Percentage of cumulative consolidated net income	50.00%
Percentage of net cash proceeds from equity issuances	50.00%
Actual fixed charge coverage ratio	3.81
Minimum fixed charge coverage ratio	2.25
Actual leverage ratio	1.54
Maximum leverage ratio	3.25
Outstanding letters of credit	5.1
Minimum net worth amount	150
Percentage of weighted average interest rate of borrowings	2.60%	2.50%
Unused borrowing capacity under Credit Agreement	227.4
Borrowings outstanding under credit facility	202.5	192.5
Revolving Credit Facility [Member]
Borrowings (Textual) [Abstract]
Aggregate principal amount	247.5
Term Loan Facility [Member]
Borrowings (Textual) [Abstract]
Aggregate principal amount	$ 202.5

XML

Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2013

Earnings Per Share [Abstract]

Reconciliation of basic and diluted earnings per share

	Three Months Ended March 31,
	2013			2012
Net income from continuing operations	$	11,369		$	587
(Loss) income from discontinued operations, net of tax		(32	)		269
Net income	$	11,337		$	856
Weighted average common shares outstanding – basic		22,139			21,775
Weighted average common stock equivalents		348			389
Weighted average common shares outstanding – diluted		22,487			22,164
Net earnings per basic share:
Net income from continuing operations	$	0.51		$	0.03
Income from discontinued operations, net of tax		—			0.01
Net income	$	0.51		$	0.04
Net earnings per diluted share:
Net income from continuing operations	$	0.51		$	0.03
(Loss) income from discontinued operations, net of tax		(0.01	)		0.01
Net income	$	0.50		$	0.04

XML

Description of Business

3 Months Ended

Mar. 31, 2013

Description of Business and Basis of Presentation [Abstract]

Description of Business

1.       Description of Business

We are a leading provider of operational and financial consulting services. We help clients in diverse industries improve performance, reduce costs, leverage technology, process and review large amounts of complex data, address regulatory changes, recover from distress and stimulate growth. Our professionals employ their expertise in administration, management, finance and operations to provide our clients with specialized analyses and customized advice and solutions that are tailored to address each client’s particular challenges and opportunities to deliver sustainable and measurable results. We provide consulting services to a wide variety of both financially sound and distressed organizations, including healthcare organizations, leading academic institutions, Fortune 500 companies, governmental entities and law firms.

XML

Consolidated Balance Sheets (Unaudited) (Parenthetical) (USD $)	Mar. 31, 2013	Dec. 31, 2012
Consolidated Balance Sheets [Abstract]
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	25,184,665	24,793,327
Treasury stock, shares	1,893,745	1,880,809

XML

Other Comprehensive (Loss) Income

3 Months Ended

Mar. 31, 2013

Other Comprehensive (Loss) Income [Abstract]

Other Comprehensive (Loss) Income

11.       Other Comprehensive (Loss) Income

The table below sets forth the components of other comprehensive (loss) income, net of tax, for the three months ended March 31, 2013 and 2012.

	Three Months Ended March 31, 2013									Three Months Ended March 31, 2012
	Before Taxes			Tax (Expense) Benefit			Net of Taxes			Before Taxes			Tax (Expense) Benefit			Net of Taxes
Other comprehensive (loss) income:
Foreign currency translation adjustment	$	(1,048	)	$	51		$	(997	)	$	353		$	(114	)		239
Unrealized gain on cash flow hedges:
Change in fair value		(25	)		11			(14	)		(173	)		70			(103	)
Reclassification adjustments into earnings		137			(55	)		82			254			(102	)		152
Net unrealized gain		112			(44	)		68			81			(32	)		49
Other comprehensive (loss) income	$	(936	)	$	7			(929	)	$	434		$	(146	)		288

Amounts reclassified from accumulated other comprehensive loss related to our cash flow hedges are recorded to Interest expense, net of interest income.

Accumulated other comprehensive loss, net of tax, includes the following components:

	Foreign Currency Translation Adjustments			Net Unrealized Gains/(Losses) on Derivatives			Accumulated Other Comprehensive Loss
Balance, December 31, 2012	$	(805	)	$	(554	)	$	(1,359	)
Current period change		(997	)		68			(929	)
Balance, March 31, 2013	$	(1,802	)	$	(486	)	$	(2,288	)

XML

Document and Entity Information	3 Months Ended
	Mar. 31, 2013	Apr. 18, 2013
Document and Entity Information [Abstract]
Entity Registrant Name	Huron Consulting Group Inc.
Entity Central Index Key	0001289848
Document Type	10-Q
Document Period End Date	Mar. 31, 2013
Amendment Flag	false
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		23,277,877

XML

Income Taxes

3 Months Ended

Mar. 31, 2013

Income Taxes [Abstract]

Income Taxes

12.       Income Taxes

The Company’s effective tax rates for the three months ended March 31, 2013 and 2012 were 41.7% and 72.1%, respectively. The effective tax rate in the first quarter of 2013 was slightly higher than the statutory rate, inclusive of state income taxes, due primarily to the impact of foreign losses with no tax benefit and certain non-deductible business expenses, partially offset by the impact of the retroactive reinstatement of the federal research and development tax credit, which was enacted during the quarter. The effective tax rate in the first quarter of 2012 was higher than the statutory rate, inclusive of state income taxes, due primarily to the impact of foreign losses with no tax benefit and certain non-deductible expenses. The foreign losses with no tax benefit and the non-deductible expenses had a larger impact on our effective tax rate in the first quarter of 2012 compared to 2013 due to the lower pretax income from continuing operations in the first quarter of 2012.

XML

Consolidated Statements of Earnings and Other Comprehensive Income (Unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Revenues and reimbursable expenses:
Revenues	$ 164,036	$ 138,637
Reimbursable expenses	15,336	13,796
Total revenues and reimbursable expenses	179,372	152,433
Direct costs and reimbursable expenses (exclusive of depreciation and amortization shown in operating expenses):
Direct costs	106,128	96,781
Amortization of intangible assets and software development costs	658	1,142
Reimbursable expenses	15,351	13,818
Total direct costs and reimbursable expenses	122,137	111,741
Operating expenses:
Selling, general and administrative	32,263	30,067
Restructuring charges		830
Restatement related expenses		1,505
Litigation settlement gain	(1,150)
Depreciation and amortization	4,779	4,653
Total operating expenses	35,892	37,055
Operating income	21,343	3,637
Other income (expense), net:
Interest expense, net of interest income	(1,863)	(1,866)
Other income, net	13	333
Total other expense, net	(1,850)	(1,533)
Income from continuing operations before income tax expense	19,493	2,104
Income tax expense	8,124	1,517
Net income from continuing operations	11,369	587
(Loss) income from discontinued operations, net of tax	(32)	269
Net income	11,337	856
Net earnings per basic share:
Net income from continuing operations	$ 0.51	$ 0.03
Income from discontinued operations, net of tax		$ 0.01
Net income	$ 0.51	$ 0.04
Net earnings per diluted share:
Net income from continuing operations	$ 0.51	$ 0.03
Income from discontinued operations, net of tax	$ (0.01)	$ 0.01
Net income	$ 0.50	$ 0.04
Weighted average shares used in calculating earnings per share:
Basic	22,139	21,775
Diluted	22,487	22,164
Comprehensive income:
Net income	11,337	856
Foreign currency translation (loss) gain, net of tax	(997)	239
Unrealized gain on cash flow hedging instruments, net of tax	68	49
Other comprehensive (loss) income	(929)	288
Comprehensive income	$ 10,408	$ 1,144

XML

Earnings Per Share

3 Months Ended

Mar. 31, 2013

Earnings Per Share [Abstract]

Earnings Per Share

6.       Earnings Per Share

Basic earnings per share excludes dilution and is computed by dividing net income by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Diluted earnings per share reflects the potential reduction in earnings per share that could occur if securities or other contracts to issue common stock were exercised or converted into common stock under the treasury stock method. Earnings per share under the basic and diluted computations are as follows:

	Three Months Ended March 31,
	2013			2012
Net income from continuing operations	$	11,369		$	587
(Loss) income from discontinued operations, net of tax		(32	)		269
Net income	$	11,337		$	856
Weighted average common shares outstanding – basic		22,139			21,775
Weighted average common stock equivalents		348			389
Weighted average common shares outstanding – diluted		22,487			22,164
Net earnings per basic share:
Net income from continuing operations	$	0.51		$	0.03
Income from discontinued operations, net of tax		—			0.01
Net income	$	0.51		$	0.04
Net earnings per diluted share:
Net income from continuing operations	$	0.51		$	0.03
(Loss) income from discontinued operations, net of tax		(0.01	)		0.01
Net income	$	0.50		$	0.04

The computation of diluted earnings per share excludes unvested restricted common stock, outstanding options and other common stock equivalents in periods where inclusion of such potential common stock instruments would be anti-dilutive. The weighted average common stock equivalents presented above do not include the effect of approximately 78,900 and 22,000 common stock equivalents for the three months ended March 31, 2013 and 2012, respectively, because their inclusion would be anti-dilutive.

XML

Goodwill and Intangible Assets

3 Months Ended

Mar. 31, 2013

Goodwill and Intangible Assets [Abstract]

Goodwill and Intangible Assets

5.       Goodwill and Intangible Assets

The table below sets forth the changes in the carrying amount of goodwill by segment for the three months ended March 31, 2013.

	Current Segments
Former Segments	Huron Healthcare		Huron Legal			Huron Education and Life Sciences		Huron Financial			Total
Health and Education Consulting	$	355,880	$	—		$	94,601	$	—		$	450,481
Legal Consulting		—		52,947			—		—			52,947
Financial Consulting		—		—			—		159,077			159,077
Total new alignment as of December 31, 2012		355,880		52,947			94,601		159,077			662,505
Accumulated impairment		—		—			—		(142,983	)		(142,983	)
Goodwill, net as of December 31, 2012		355,880		52,947			94,601		16,094			519,522
Foreign currency translation		—		(606	)		—		—			(606	)
Goodwill, net as of March 31, 2013	$	355,880	$	52,341		$	94,601	$	16,094		$	518,916

During the first quarter of 2013, we changed our internal financial reporting structure. Under the new structure, our former Health and Education Consulting segment became two separate segments: Huron Healthcare and Huron Education and Life Sciences. In addition, certain immaterial practices which were historically part of our Health and Education Consulting segment were combined and disclosed in our All Other segment. The Legal Consulting segment is now referred to as Huron Legal and the Financial Consulting segment is now referred to as Huron Financial. The structure of the Legal Consulting and Financial Consulting segments did not change. As a result of these changes, we now have five reporting segments, which are the same as our operating segments and reporting units.

In accordance with ASC 350, “Intangibles – Goodwill and Other”, we reassigned the goodwill balance of the Health and Education Consulting segment using the relative fair value approach based on an evaluation of expected future discounted cash flows. Based on this relative fair value analysis, we reassigned $355.9 million of goodwill to Huron Healthcare and $94.6 million of goodwill to Huron Education and Life Sciences.

In conjunction with the goodwill reassignment, we performed the first step of the goodwill impairment test for the goodwill balances within our Huron Healthcare and Huron Education and Life Sciences reporting units as of January 2, 2013. Based on the result of the first step of the goodwill impairment test, we determined that the fair values of our Huron Healthcare and Huron Education and Life Sciences reporting units exceeded their carrying values. Since the fair values of both reporting units exceeded their carrying values, the second step of the goodwill impairment test was not necessary.

In estimating the fair value of our Huron Healthcare and Huron Education and Life Sciences reporting units, we relied on a combination of the income approach and the market approach, utilizing the guideline company method, with a fifty-fifty weighting. For companies providing services similar to those provided by us, the income and market approaches will generally provide the most reliable indications of value because the value of such companies is dependent on their ability to generate earnings.

In the income approach, we utilized a discounted cash flow analysis, which involved estimating the expected after-tax cash flows that will be generated by our reporting units and then discounting those cash flows to present value reflecting the relevant risks associated with the reporting units and the time value of money. This approach requires the use of significant estimates and assumptions, including long-term projections of future cash flows, market conditions, discount rates reflecting the risk inherent in future cash flows, revenue growth, perpetual growth rates and profitability, among others. In estimating future cash flows, we relied on an internally generated six-year forecast. For periods after the six-year forecast, we assumed a 3.5% long-term annual revenue growth rate. Our forecast is based on our historical experience, current backlog, expected market demand, and other industry information. Our discounted cash flow analysis assumed a 13% weighted average cost of capital (“WACC”) discount rate for each reporting unit.

In the market approach, we utilized the guideline company method, which involved calculating valuation multiples based on operating data from guideline publicly traded companies. Multiples derived from guideline companies provide an indication of how much a knowledgeable investor in the marketplace would be willing to pay for a company. These multiples were then adjusted for factors similar to those used in a discounted cash flow analysis and applied to the operating data for our reporting units to arrive at an indication of value.

Determining the fair value of a reporting unit requires us to make significant judgments, estimates and assumptions. While we believe that the estimates and assumptions underlying our valuation methodology are reasonable, these estimates and assumptions could have a significant impact on whether or not an impairment charge is recognized and also the magnitude of any such charge. The results of an impairment analysis are as of a point in time. There is no assurance that the actual future earnings or cash flows of our reporting units will not differ significantly from our projections. We will monitor any changes to our assumptions and will evaluate goodwill as deemed warranted during future periods. Any significant decline in our operations could result in goodwill impairment charges.

Intangible assets as of March 31, 2013 and December 31, 2012 consisted of the following:

		March 31, 2013				December 31, 2012
	Useful Life in Years	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Customer relationships	3 to 13	$	24,634	$	11,219	$	24,738	$	10,268
Non-competition agreements	1 to 6		4,684		3,295		4,684		3,067
Trade names	1 to 8		150		20		150		8
Technology and software	5		4,041		1,953		4,041		1,751
Document reviewer database	3		450		135		450		90
Total		$	33,959	$	16,622	$	34,063	$	15,184

Identifiable intangible assets with finite lives are amortized over their estimated useful lives. The majority of customer relationships are amortized on an accelerated basis to correspond to the cash flows expected to be derived from the relationships. All other customer relationships, non-competition agreements, trade names, technology and software, and the document reviewer database are amortized on a straight-line basis.

Intangible assets amortization expense was $1.5 million and $1.6 million for the three months ended March 31, 2013 and 2012, respectively. Estimated annual intangible assets amortization expense is $5.8 million for 2013, $4.5 million for 2014, $3.1 million for 2015, $1.8 million for 2016, $1.2 million for 2017 and $0.7 million for 2018. Actual future amortization expense could differ from these estimated amounts as a result of future acquisitions and other factors.

XML

Goodwill and Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2013

Goodwill and Intangible Assets [Abstract]

Changes in the carrying amount of goodwill

	Current Segments
Former Segments	Huron Healthcare		Huron Legal			Huron Education and Life Sciences		Huron Financial			Total
Health and Education Consulting	$	355,880	$	—		$	94,601	$	—		$	450,481
Legal Consulting		—		52,947			—		—			52,947
Financial Consulting		—		—			—		159,077			159,077
Total new alignment as of December 31, 2012		355,880		52,947			94,601		159,077			662,505
Accumulated impairment		—		—			—		(142,983	)		(142,983	)
Goodwill, net as of December 31, 2012		355,880		52,947			94,601		16,094			519,522
Foreign currency translation		—		(606	)		—		—			(606	)
Goodwill, net as of March 31, 2013	$	355,880	$	52,341		$	94,601	$	16,094		$	518,916

Intangible assets

		March 31, 2013				December 31, 2012
	Useful Life in Years	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Customer relationships	3 to 13	$	24,634	$	11,219	$	24,738	$	10,268
Non-competition agreements	1 to 6		4,684		3,295		4,684		3,067
Trade names	1 to 8		150		20		150		8
Technology and software	5		4,041		1,953		4,041		1,751
Document reviewer database	3		450		135		450		90
Total		$	33,959	$	16,622	$	34,063	$	15,184

XML

Commitments, Contingencies and Guarantees

3 Months Ended

Mar. 31, 2013

Commitments, Contingencies and Guarantees [Abstract]

Commitments, Contingencies and Guarantees

13.       Commitments, Contingencies and Guarantees

Litigation

Qui Tam Action

On December 9, 2009, plaintiff, Associates Against Outlier Fraud, filed a first amended qui tam complaint against Huron Consulting Group Inc. and others under the federal and New York state False Claims Act (“FCA”) in the United States District Court for the Southern District of New York. The federal and state FCA authorize private individuals (known as “relators”) to sue on behalf of the government (known as “qui tam” actions) alleging that false or fraudulent claims were knowingly submitted to the government. Once a qui tam action is filed, the government may elect to intervene in the action. If the government declines to intervene, the relator may proceed with the action. Under the federal and state FCA, the government may recover treble damages and civil penalties (civil penalties of up to $11,000 per violation under the federal FCA and $12,000 per violation under the state FCA). On January 6, 2010, the United States declined to intervene in the lawsuit. After the Court granted Huron’s motion to dismiss without prejudice, on September 29, 2010, the relator filed a second amended complaint alleging that Huron and others caused St. Vincent Catholic Medical Center to receive more than $30 million in inflated outlier payments under the Medicare and Medicaid programs in violation of the federal and state FCA and seeking to recover an unspecified amount of civil penalties. On March 8, 2013, the Court granted Huron’s motion for summary judgment and dismissed relator’s second amended complaint in its entirety with prejudice. As a result, we reversed the charge of $1.2 million relating to settlement discussions which we recorded in the second quarter of 2012, in accordance with FASB ASC Topic 450, “Contingencies.” The relator filed an appeal on April 2, 2013. On April 8, 2013, Huron filed an appeal of an earlier denial of a motion to dismiss filed by Huron which argued that relator’s action was barred because, under the FCA jurisdictional bar, the action was based on publicly disclosed information and relator cannot qualify as an original source. We continue to believe that the claims are without merit and intend to vigorously defend ourselves in this matter.

From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. As of the date of this Quarterly Report on Form 10-Q, we are not a party to or threatened with any other litigation or legal proceeding that, in the current opinion of management, could have a material adverse effect on our financial position or results of operations. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results.

Guarantees and Indemnification

Guarantees in the form of letters of credit totaling $5.1 million were outstanding at both March 31, 2013 and December 31, 2012 to support certain office lease obligations as well as Middle East performance and bid bonds.

To the extent permitted by law, our bylaws and articles of incorporation require that we indemnify our officers and directors against judgments, fines and amounts paid in settlement, including attorneys’ fees, incurred in connection with civil or criminal action or proceedings, as it relates to their services to us if such person acted in good faith. Although there is no limit on the amount of indemnification, we may have recourse against our insurance carrier for certain payments made.

XML

Derivative Instruments and Hedging Activity

3 Months Ended

Mar. 31, 2013

Derivative Instruments and Hedging Activity [Abstract]

Derivative Instruments and Hedging Activity

9.       Derivative Instruments and Hedging Activity

On March 20, 2009, we entered into an interest rate swap agreement for a notional amount of $100.0 million effective on March 31, 2009 and ending on February 23, 2012. We entered into this derivative instrument to hedge against the risk of changes in future cash flows related to changes in interest rates on $100.0 million of the total variable-rate borrowings outstanding described above in Note 7 “Borrowings.” Under the terms of the interest rate swap agreement, we received from the counterparty interest on the $100.0 million notional amount based on one-month LIBOR and we paid to the counterparty a fixed rate of 1.715%. This swap effectively converted $100.0 million of our variable-rate borrowings to fixed-rate borrowings beginning on March 31, 2009 and through February 23, 2012.

On December 8, 2011, we entered into a forward amortizing interest rate swap agreement effective on February 29, 2012 and ending on April 14, 2016. We entered into this derivative instrument to continue hedging against the interest rate risks of our variable-rate borrowings described above. The swap had an initial notional amount of $56.6 million and amortizes throughout the term. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one-month LIBOR and we pay to the counterparty a fixed rate of 0.9875%.

On May 30, 2012, we entered into an additional forward amortizing interest rate swap agreement effective on May 31, 2012 and ending on April 14, 2016. We entered into this derivative instrument to further hedge against the interest rate risks of our variable-rate borrowings described above. The swap had an initial notional amount of $37.0 million and amortizes throughout the term. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one-month LIBOR and we pay to the counterparty a fixed rate of 0.70%.

FASB ASC Topic 815, “Derivatives and Hedging,” requires companies to recognize all derivative instruments as either assets or liabilities at fair value on the balance sheet. In accordance with ASC Topic 815, we have designated these derivative instruments as cash flow hedges. As such, changes in the fair value of the derivative instruments are recorded as a component of other comprehensive income (“OCI”) to the extent of effectiveness and reclassified into interest expense upon settlement. The ineffective portion of the change in fair value of the derivative instruments is recognized in interest expense. As of March 31, 2013, it was anticipated that $0.3 million of the net losses, net of tax, currently recorded in OCI will be reclassified into earnings within the next 12 months. Our interest rate swap agreements were effective during the three months ended March 31, 2013.

The tables below set forth additional information relating to these interest rate swaps designated as cash flow hedging instruments as of March 31, 2013 and December 31, 2012.

	Fair Value (Derivative Liability)
Balance Sheet Location	March 31, 2013		December 31, 2012
Accrued expenses	$	455	$	493
Deferred compensation and other liabilities	$	365	$	439

We do not use derivative instruments for trading or other speculative purposes, and we did not have any other derivative instruments or hedging activities as of March 31, 2013. Refer to Note 11 “Other Comprehensive (Loss) Income” for additional information on our derivative instruments.

On April 4, 2013, we entered into a one-year forward amortizing interest rate swap agreement effective on March 31, 2014 and ending on August 31, 2017. We entered into this derivative instrument to further hedge against the interest rate risks of our variable-rate borrowings described above. The swap has an initial notional amount of $60.0 million and amortizes throughout the term. Under the terms of the interest rate swap agreement, we will receive from the counterparty interest on the notional amount based on one-month LIBOR and we will pay to the counterparty a fixed rate of 0.985%.

XML

Borrowings

3 Months Ended

Mar. 31, 2013

Borrowings [Abstract]

Borrowings

7.       Borrowings

During 2011, the Company and certain of the Company’s subsidiaries as guarantors entered into an Amended and Restated Credit Agreement with various financial institutions, as amended by the first amendment to the credit agreement dated as of August 31, 2012 (collectively, the “2011 Credit Agreement”). The 2011 Credit Agreement replaced the previous Credit Agreement, dated as of June 7, 2006, and all subsequent amendments thereto, by and among the Company and the lenders therein.

The 2011 Credit Agreement consists of a senior secured credit facility in an aggregate principal amount of $450.0 million comprised of a five-year revolving credit facility (“Revolver”) under which the Company may borrow from time to time up to $247.5 million and a $202.5 million five-year term loan facility (“Term Loan”) that was funded in a single advance on the closing date of the first amendment. The 2011 Credit Agreement provides for the option to increase the revolving credit facility in an aggregate amount of up to $50 million subject to certain requirements as defined in the 2011 Credit Agreement. The proceeds of the senior secured credit facility were used to refinance existing indebtedness and will continue to be used for working capital, capital expenditures, and other corporate purposes.

The obligations under the 2011 Credit Agreement are secured pursuant to a Security Agreement with Bank of America as Administrative Agent. The Security Agreement grants Bank of America, N.A. for the ratable benefit of the lenders under the 2011 Credit Agreement, a first-priority lien, subject to permitted liens, on substantially all of the personal property assets of the Company and the subsidiary guarantors. The Revolver and Term Loan are also secured by a pledge of 100% of the voting stock or other equity interests in our domestic subsidiaries and 65% of the voting stock or other equity interests in our foreign subsidiaries.

Fees and interest on borrowings vary based on our total debt to earnings before interest, taxes, depreciation and amortization (“EBITDA”) ratio as set forth in the 2011 Credit Agreement. Interest is based on a spread over the London Interbank Offered Rate (“LIBOR”) or a spread over the base rate, as selected by the Company. The base rate is the greater of (a) the Federal Funds Rate plus 0.5%, (b) the Prime Rate and (c) except during a Eurodollar Unavailability Period, the Eurodollar Rate plus 1.0%.

The Term Loan, as amended, is subject to scheduled quarterly amortization payments equal to 4.9% of the original principal balance in 2012, which was paid as of December 31, 2012, 11.7% in 2013, 12.4% in 2014, 14.2% in 2015, 14.8% in 2016 and 42.0% in 2017, as set forth in the 2011 Credit Agreement. The maturity date for the Term Loan is August 31, 2017, at which time the outstanding principal balance and all accrued interest will be due and payable in full. All outstanding borrowings under the Revolver, as amended, will be due upon expiration of the 2011 Credit Agreement on August 31, 2017.

Under the 2011 Credit Agreement, dividends are restricted to an amount up to $50 million plus 50% of cumulative consolidated net income from the closing date of the 2011 Credit Agreement plus 50% of the net cash proceeds from equity issuances. In addition, certain acquisitions and similar transactions need to be approved by the lenders.

The 2011 Credit Agreement contains quarterly financial covenants that require us to maintain a minimum fixed charge coverage ratio of 2.25 to 1.00 and a maximum leverage ratio that varies throughout the term and was 3.25 to 1.00 as of March 31, 2013, as those ratios are defined therein, as well as a minimum net worth greater than $150 million. At March 31, 2013, we were in compliance with these financial covenants with a fixed charge coverage ratio of 3.81 to 1.00, a leverage ratio of 1.54 to 1.00, and net worth greater than $150 million. At December 31, 2012, we were also in compliance with our financial debt covenants.

The borrowing capacity under the 2011 Credit Agreement is reduced by any outstanding letters of credit and payments under the Term Loan. At March 31, 2013, outstanding letters of credit totaled $5.1 million and are primarily used as security deposits for our office facilities. As of March 31, 2013, the unused borrowing capacity under the 2011 Credit Agreement was $227.4 million. Borrowings outstanding under this credit facility at March 31, 2013 totaled $202.5 million. These borrowings carried a weighted average interest rate of 2.6%, including the effect of the interest rate swaps described below in Note 9 “Derivative Instruments and Hedging Activity.” Borrowings outstanding at December 31, 2012 were $192.5 million and carried a weighted average interest rate of 2.5%. Effective March 31, 2013, we have classified as current liabilities, the scheduled quarterly principal payments due under the Term Loan within twelve months of the balance sheet date, as we intend to make these payments with cash from operations rather than from availability under the Revolver.

XML

Restructuring Charges

3 Months Ended

Mar. 31, 2013

Restructuring Charges [Abstract]

Restructuring Charges

8.       Restructuring Charges

We did not incur restructuring charge expense during the first quarter of 2013. As of March 31, 2013, our restructuring charge liability is $1.0 million, and primarily consists of the present value of remaining lease payments, net of estimated sublease income, for our vacated office spaces in San Francisco and Washington, D.C. The restructuring charge liability is included as a component of Accrued expenses and Deferred compensation and other liabilities.

During the first quarter of 2012, we incurred a $0.8 million pre-tax restructuring charge, primarily consisting of accelerated depreciation on leasehold improvements related to the anticipated relocation of one of our New York City office locations, which we relocated during the fourth quarter of 2012. We did not incur a lease charge related to the relocation of our New York City office space as income from our subtenant is expected to more than offset our remaining lease obligations through 2016, net of our deferred lease liability.

XML

Fair Value of Financial Instruments

3 Months Ended

Mar. 31, 2013

Fair Value of Financial Instruments [Abstract]

Fair Value of Financial Instruments

10.       Fair Value of Financial Instruments

Certain of our assets and liabilities are measured at fair value. FASB ASC Topic 820, “Fair Value Measurements and Disclosures,” defines fair value as the price that would be received to sell an asset or the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy for inputs used in measuring fair value and requires companies to maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy consists of three levels based on the objectivity of the inputs as follows:

Level 1 Inputs	Quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.
Level 2 Inputs	Quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
Level 3 Inputs	Unobservable inputs for the asset or liability, and include situations in which there is little, if any, market activity for the asset or liability.

Cash and cash equivalents are stated at cost, which approximates fair market value. The carrying values for receivables from clients, unbilled services, accounts payable, deferred revenues and other accrued liabilities reasonably approximate fair market value due to the nature of the financial instrument and the short-term maturity of these items. The carrying values of our bank borrowings reported in the Consolidated Balance Sheets approximate fair value, using level 2 inputs, since they bear interest at variable rates based on market rates as set forth in the 2011 Credit Agreement. Refer to Note 7 “Borrowings.”

The table below sets forth our fair value hierarchy for our financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2013 and December 31, 2012.

	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
March 31, 2013
Asset:
Promissory note	$	—	$	—	$	2,974	$	2,974
Liabilities:
Interest rate swaps	$	—	$	820	$	—	$	820
Deferred acquisition payments		—		—		10,542		10,542
Total liabilities	$	—	$	820	$	10,542	$	11,362
December 31, 2012
Asset:
Promissory note	$	—	$	—	$	2,907	$	2,907
Liabilities:
Interest rate swaps	$	—	$	932	$	—	$	932
Deferred acquisition payments		—		—		10,525		10,525
Total liabilities	$	—	$	932	$	10,525	$	11,457

As part of the consideration received for the sale of our AA practice on December 30, 2011, the Company received a $3.5 million promissory note payable over four years. The note will be paid to the Company in quarterly installments of approximately $0.2 million beginning in the second quarter of 2013 with a final payment of approximately $1.1 million on the maturity date in December 2015. The fair value of the note is based on the net present value of the projected cash flows using a discount rate of 14%, which accounts for the risks associated with the note. The increase in the fair value of the note during the first three months of 2013 reflects the accretion of interest income in excess of interest payments received.

The fair value of the interest rate swaps was derived using estimates to settle the interest rate swap agreements, which are based on the net present value of expected future cash flows on each leg of the swaps utilizing market-based inputs and discount rates reflecting the risks involved.

Deferred acquisition payments are included in the total purchase consideration for certain business acquisitions the Company has completed, and represent fixed future payments owed to the sellers of those businesses. The fair value of the deferred acquisition payments is based on the payment terms, which range from 1 to 2 years, and the net present value of expected cash flows using a discount rate ranging from 4% to 8%. The increase in the fair value of the deferred acquisition payments during the first three months of 2013 reflects the accretion of interest expense in excess of interest payments made.

XML

Earnings Per Share (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Reconciliation of basic and diluted earnings per share
Net income from continuing operations	$ 11,369	$ 587
(Loss) income from discontinued operations, net of tax	(32)	269
Net income	$ 11,337	$ 856
Weighted average common shares outstanding - basic	22,139	21,775
Weighted average common stock equivalents	348	389
Weighted average common shares outstanding - diluted	22,487	22,164
Net earnings per basic share:
Net income from continuing operations	$ 0.51	$ 0.03
Income from discontinued operations, net of tax		$ 0.01
Net income	$ 0.51	$ 0.04
Net earnings per diluted share:
Net income from continuing operations	$ 0.51	$ 0.03
(Loss) income from discontinued operations, net of tax	$ (0.01)	$ 0.01
Net income	$ 0.50	$ 0.04

XML

New Accounting Pronouncements (Policies)

3 Months Ended

Mar. 31, 2013

New Accounting Pronouncements [Abstract]

Comprehensive Income

In February 2013, the FASB issued ASU No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, which amends current accounting guidance on comprehensive income. The guidance requires an entity to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income if the amount is reclassified to net income in its entirety in the same reporting period. For other amounts not required to be reclassified in their entirety to net income in the same reporting period, a cross reference to other disclosures that provide additional detail about the reclassification amounts is required. The Company adopted this guidance effective January 1, 2013. The guidance required a change in disclosure only and did not have any effect on the Company’s consolidated financial statements.

Cumulative Translation Adjustment

In March 2013, the FASB issued ASU No. 2013-05, Parent’s Accounting for the Cumulative Translation Adjustment Upon Derecognition of Certain Subsidiaries or Groups of Assets Within a Foreign Entity or of an Investment in a Foreign Entity, which amends current accounting guidance on foreign currency matters. This guidance requires that the entire amount of a cumulative translation adjustment related to an entity’s investment in a foreign entity should be released when there has been a: (i) sale of a subsidiary or group of net assets within a foreign entity and the sale represents the substantially complete liquidation of the investment in the foreign entity, (ii) loss of a controlling financial interest in an investment in a foreign entity, and (iii) step acquisition for a foreign entity. This guidance will be effective for the Company beginning in the first quarter of 2014. We do not expect the adoption to have a material impact on our consolidated financial statements.

Derivatives and Hedging

FASB ASC Topic 815, “Derivatives and Hedging,” requires companies to recognize all derivative instruments as either assets or liabilities at fair value on the balance sheet. In accordance with ASC Topic 815, we have designated these derivative instruments as cash flow hedges. As such, changes in the fair value of the derivative instruments are recorded as a component of other comprehensive income (“OCI”) to the extent of effectiveness and reclassified into interest expense upon settlement. The ineffective portion of the change in fair value of the derivative instruments is recognized in interest expense. As of March 31, 2013, it was anticipated that $0.3 million of the net losses, net of tax, currently recorded in OCI will be reclassified into earnings within the next 12 months. Our interest rate swap agreements were effective during the three months ended March 31, 2013.

Fair Value Measurements and Disclosures

Certain of our assets and liabilities are measured at fair value. FASB ASC Topic 820, “Fair Value Measurements and Disclosures,” defines fair value as the price that would be received to sell an asset or the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy for inputs used in measuring fair value and requires companies to maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy consists of three levels based on the objectivity of the inputs as follows:

Level 1 Inputs	Quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.
Level 2 Inputs	Quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
Level 3 Inputs	Unobservable inputs for the asset or liability, and include situations in which there is little, if any, market activity for the asset or liability.

Cash and cash equivalents are stated at cost, which approximates fair market value. The carrying values for receivables from clients, unbilled services, accounts payable, deferred revenues and other accrued liabilities reasonably approximate fair market value due to the nature of the financial instrument and the short-term maturity of these items. The carrying values of our bank borrowings reported in the Consolidated Balance Sheets approximate fair value, using level 2 inputs, since they bear interest at variable rates based on market rates as set forth in the 2011 Credit Agreement. Refer to Note 7 “Borrowings.”

Contingencies

Qui Tam Action

On December 9, 2009, plaintiff, Associates Against Outlier Fraud, filed a first amended qui tam complaint against Huron Consulting Group Inc. and others under the federal and New York state False Claims Act (“FCA”) in the United States District Court for the Southern District of New York. The federal and state FCA authorize private individuals (known as “relators”) to sue on behalf of the government (known as “qui tam” actions) alleging that false or fraudulent claims were knowingly submitted to the government. Once a qui tam action is filed, the government may elect to intervene in the action. If the government declines to intervene, the relator may proceed with the action. Under the federal and state FCA, the government may recover treble damages and civil penalties (civil penalties of up to $11,000 per violation under the federal FCA and $12,000 per violation under the state FCA). On January 6, 2010, the United States declined to intervene in the lawsuit. After the Court granted Huron’s motion to dismiss without prejudice, on September 29, 2010, the relator filed a second amended complaint alleging that Huron and others caused St. Vincent Catholic Medical Center to receive more than $30 million in inflated outlier payments under the Medicare and Medicaid programs in violation of the federal and state FCA and seeking to recover an unspecified amount of civil penalties. On March 8, 2013, the Court granted Huron’s motion for summary judgment and dismissed relator’s second amended complaint in its entirety with prejudice. As a result, we reversed the charge of $1.2 million relating to settlement discussions which we recorded in the second quarter of 2012, in accordance with FASB ASC Topic 450, “Contingencies.” The relator filed an appeal on April 2, 2013. On April 8, 2013, Huron filed an appeal of an earlier denial of a motion to dismiss filed by Huron which argued that relator’s action was barred because, under the FCA jurisdictional bar, the action was based on publicly disclosed information and relator cannot qualify as an original source. We continue to believe that the claims are without merit and intend to vigorously defend ourselves in this matter.

From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. As of the date of this Quarterly Report on Form 10-Q, we are not a party to or threatened with any other litigation or legal proceeding that, in the current opinion of management, could have a material adverse effect on our financial position or results of operations. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results.

Segment Reporting

Segments are defined by FASB ASC Topic 280, “Segment Reporting,” as components of a company in which separate financial information is available and is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. In the first quarter of 2013, the Company reorganized its internal financial reporting structure. Under the new structure, the Company began reporting information as five operating segments: Huron Healthcare; Huron Legal; Huron Education and Life Sciences; Huron Financial; and All Other. Our chief operating decision maker manages the business under these five operating segments.

XML

Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2013

Fair Value of Financial Instruments [Abstract]

Financial assets and liabilities measured at fair value on a recurring basis

	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
March 31, 2013
Asset:
Promissory note	$	—	$	—	$	2,974	$	2,974
Liabilities:
Interest rate swaps	$	—	$	820	$	—	$	820
Deferred acquisition payments		—		—		10,542		10,542
Total liabilities	$	—	$	820	$	10,542	$	11,362
December 31, 2012
Asset:
Promissory note	$	—	$	—	$	2,907	$	2,907
Liabilities:
Interest rate swaps	$	—	$	932	$	—	$	932
Deferred acquisition payments		—		—		10,525		10,525
Total liabilities	$	—	$	932	$	10,525	$	11,457

XML

Fair Value of Financial Instruments (Details Textual) (USD $) In Millions, unless otherwise specified	3 Months Ended	12 Months Ended
	Mar. 31, 2013	Dec. 31, 2011	Dec. 30, 2011
Fair Value of Financial Instruments (Textual) [Abstract]
Discount rate used to value promissory note	14.00%
Fair Value of Financial Instruments (Additional Textual) [Abstract]
Promissory note received for sale of AA			$ 3.5
Promissory note payable period		4 years
Consideration received as promissory note payable, 2013	0.2
Consideration received as promissory note payable, 2015	$ 1.1
Promissory note [Member]
Fair Value of Financial Instruments (Textual) [Abstract]
Promissory note payable maturity date	Dec. 31, 2015
Maximum [Member]
Fair Value of Financial Instruments (Textual) [Abstract]
Discount rate used to value promissory note	8.00%
Deferred acquisition payment terms	2 years
Minimum [Member]
Fair Value of Financial Instruments (Textual) [Abstract]
Discount rate used to value promissory note	4.00%
Deferred acquisition payment terms	1 year

XML

Consolidated Statements of Stockholders' Equity (Unaudited) (USD $) In Thousands, except Share data, unless otherwise specified	Total	Common Stock	Treasury Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2012	$ 445,321	$ 240	$ (83,715)	$ 420,825	$ 109,330	$ (1,359)
Beginning Balance, shares at Dec. 31, 2012		23,904,125	(1,889,465)
Comprehensive income	10,408				11,337	(929)
Issuance of common stock in connection with:
Restricted stock awards, net of cancellations		3	143	(146)
Restricted stock awards, net of cancellations, shares		310,001	3,549
Exercise of stock options	27			27
Exercise of stock options, shares		20,211
Share-based compensation	6,323			6,323
Shares redeemed for employee tax withholdings	(565)		(565)
Shares redeemed for employee tax withholdings, shares			(16,283)
Income tax benefit on share-based compensation	578			578
Ending Balance at Mar. 31, 2013	$ 462,092	$ 243	$ (84,137)	$ 427,607	$ 120,667	$ (2,288)
Ending Balance, shares at Mar. 31, 2013		24,234,337	(1,902,199)

XML

Discontinued Operations

3 Months Ended

Mar. 31, 2013

Discontinued Operations [Abstract]

Discontinued Operations

4.       Discontinued Operations

In recent years, we have undertaken several separate initiatives to divest certain practices within the Huron Financial segment in order to enable us to devote more of our energy and financial resources to the remaining businesses of the Company where we have a more substantial market presence. Most recently, on December 30, 2011, we sold the Accounting Advisory (“AA”) practice to a group of investors including the managing director of the practice at the time and recognized a loss of $1.9 million in connection with the sale.

The operating results of AA are reported as “discontinued operations.” All other operations of the business are considered “continuing operations.” Summarized operating results of discontinued operations are presented in the following table:

	Three Months Ended March  31,
	2013			2012
Revenues	$	33		$	390
(Loss) income from discontinued operations before income tax expense	$	(53	)	$	424
Net (loss) income from discontinued operations	$	(32	)	$	269

There were no significant assets or liabilities related to discontinued operations in the Consolidated Balance Sheets as of March 31, 2013 or December 31, 2012.

XML

Other Comprehensive (Loss) Income (Tables)

3 Months Ended

Mar. 31, 2013

Other Comprehensive (Loss) Income [Abstract]

Components of other comprehensive (loss) income, net of tax

	Three Months Ended March 31, 2013									Three Months Ended March 31, 2012
	Before Taxes			Tax (Expense) Benefit			Net of Taxes			Before Taxes			Tax (Expense) Benefit			Net of Taxes
Other comprehensive (loss) income:
Foreign currency translation adjustment	$	(1,048	)	$	51		$	(997	)	$	353		$	(114	)		239
Unrealized gain on cash flow hedges:
Change in fair value		(25	)		11			(14	)		(173	)		70			(103	)
Reclassification adjustments into earnings		137			(55	)		82			254			(102	)		152
Net unrealized gain		112			(44	)		68			81			(32	)		49
Other comprehensive (loss) income	$	(936	)	$	7			(929	)	$	434		$	(146	)		288

Components of accumulated other comprehensive loss, net of tax

	Foreign Currency Translation Adjustments			Net Unrealized Gains/(Losses) on Derivatives			Accumulated Other Comprehensive Loss
Balance, December 31, 2012	$	(805	)	$	(554	)	$	(1,359	)
Current period change		(997	)		68			(929	)
Balance, March 31, 2013	$	(1,802	)	$	(486	)	$	(2,288	)

XML

Derivative Instruments and Hedging Activity (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2012
Accrued expenses [Member]
Fair Value interest rate swaps designated as cash flow hedging instruments
Fair Value (Derivative Liability)	$ 455	$ 493
Deferred compensation and other liabilities [Member]
Fair Value interest rate swaps designated as cash flow hedging instruments
Fair Value (Derivative Liability)	$ 365	$ 439

XML

Segment Information

3 Months Ended

Mar. 31, 2013

Segment Information [Abstract]

Segment Information

14.       Segment Information

Segments are defined by FASB ASC Topic 280, “Segment Reporting,” as components of a company in which separate financial information is available and is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. In the first quarter of 2013, the Company reorganized its internal financial reporting structure. Under the new structure, the Company began reporting information as five operating segments: Huron Healthcare; Huron Legal; Huron Education and Life Sciences; Huron Financial; and All Other. Our chief operating decision maker manages the business under these five operating segments.

Under this new internal financial reporting structure, the former Health and Education Consulting segment became two separate segments: Huron Healthcare and Huron Education and Life Sciences. These practices continue to share a significant number of academic medical center clients and will continue to closely collaborate in the market. The Legal Consulting segment is now referred to as Huron Legal and the Financial Consulting segment is now referred to as Huron Financial. The structure of the Legal Consulting and Financial Consulting segments did not change. In addition, certain immaterial practices which were historically part of our Health and Education Consulting segment were combined and disclosed in our All Other segment. While our consolidated results have not been impacted, we have restated our historical segment information for consistent presentation.

• Huron Healthcare

Our Huron Healthcare segment provides consulting services to national and regional integrated health systems, physician practices, community hospitals, managed care organizations, and academic medical centers. This segment provides consulting services related to hospital or healthcare organization performance improvement, revenue cycle improvement, clinical quality and care variation, labor productivity, non-labor cost management, information technology, patient flow improvement and physician practice management.

• Huron Legal

Our Huron Legal segment provides advisory and business services to assist law departments of major global corporations and law firms with their strategy, organizational design and development, operational efficiency, and cost effectiveness. These results-driven services help reduce the amounts they spend on legal services and enhance client service. Our expertise focuses on strategic and management consulting, cost management, and technology and information management including matter management, records management, digital evidence, document review and discovery services.

• Huron Education and Life Sciences

Our Huron Education and Life Science segment provides consulting services to universities, research institutions, healthcare organizations, academic medical centers, and pharmaceutical, medical device manufacturer and biotechnology companies. We develop and implement performance improvement, technology, and research enterprise solutions to help clients address challenges relating to financial management, strategy, operational and organizational effectiveness, research administration, and regulatory compliance.

• Huron Financial

Our Huron Financial segment provides financial advisory, restructuring and turnaround, interim management, valuation, forensic and litigation, and operational improvement consulting services to companies in transition, boards of directors and investors and lenders. Our consultants provide senior level involvement and extensive industry experience to drive results. Our experienced leadership, management depth and flexible staffing model allow us to efficiently lead projects ranging from middle market to large company assignments. We draw on career experience gathered from operations, lending, investment banking, portfolio and asset management, public accounting, and management consulting to provide practical business solutions.

• All Other

Our All Other segment consists of any lines of business not managed by our other four operating segments. In 2013 and 2012, the All Other segment consisted of our foreign healthcare and strategic consulting operations based in the Middle East.

Segment operating income consists of the revenues generated by a segment, less the direct costs of revenue and selling, general and administrative costs that are incurred directly by the segment. Unallocated corporate costs include costs related to administrative functions that are performed in a centralized manner that are not attributable to a particular segment. These administrative function costs include costs for corporate office support, certain office facility costs, costs relating to accounting and finance, human resources, legal, marketing, information technology and Company-wide business development functions, as well as costs related to overall corporate management.

The table below sets forth information about our operating segments for the three months ended March 31, 2013 and 2012, along with the items necessary to reconcile the segment information to the totals reported in the accompanying Consolidated Financial Statements.

	Three Months Ended March 31,
	2013			2012
Huron Healthcare:
Revenues	$	78,745		$	63,465
Operating income	$	31,161		$	15,838
Segment operating income as a percent of segment revenues		39.6	%		25.0	%
Huron Legal:
Revenues	$	40,944		$	41,383
Operating income	$	2,938		$	9,511
Segment operating income as a percent of segment revenues		7.2	%		23.0	%
Huron Education and Life Sciences:
Revenues	$	35,726		$	27,676
Operating income	$	9,352		$	6,458
Segment operating income as a percent of segment revenues		26.2	%		23.3	%
Huron Financial:
Revenues	$	8,582		$	5,849
Operating income	$	3,379		$	233
Segment operating income as a percent of segment revenues		39.4	%		4.0	%
All Other:
Revenues	$	39		$	264
Operating loss	$	(172	)	$	(799	)
Segment operating loss as a percent of segment revenues		N/M			N/M
Total Company:
Revenues	$	164,036		$	138,637
Reimbursable expenses		15,336			13,796
Total revenues and reimbursable expenses	$	179,372		$	152,433
Statements of Earnings reconciliation:
Segment operating income	$	46,658		$	31,241
Charges not allocated at the segment level:
Other selling, general and administrative expenses		20,536			22,951
Depreciation and amortization expense		4,779			4,653
Other expense, net		1,850			1,533
Income from continuing operations before income tax expense	$	19,493		$	2,104

N/M - Not meaningful

	March 31, 2013		December 31, 2012
Segment Assets:
Huron Healthcare	$	78,050	$	60,288
Huron Legal		44,973		51,594
Huron Education and Life Sciences		31,985		31,129
Huron Financial		5,394		1,462
All Other		41		50
Unallocated assets (1)		615,632		643,377
Total assets	$	776,075	$	787,900

(1) Goodwill and intangible assets are included in unallocated assets, as management does not evaluate these items at the segment level when assessing segment performance or allocating resources.

At both March 31, 2013 and December 31, 2012, no single client accounted for greater than 10% of our combined receivables and unbilled services balances. No single client generated greater than 10% of our consolidated revenues during the three months ended March 31, 2013 and 2012.